Nutrition and gastrointestinal cancer risk - a study of individual food groups by Tse, Genevieve
Copyright and use of this thesis
This thesis must be used in accordance with the 
provisions of the Copyright Act 1968.
Reproduction of material protected by copyright 
may be an infringement of copyright and 
copyright owners may be entitled to take 
legal action against persons who infringe their 
copyright.
Section 51 (2) of the Copyright Act permits 
an authorized officer of a university library or 
archives to provide a copy (by communication 
or otherwise) of an unpublished thesis kept in 
the library or archives, to a person who satisfies 
the authorized officer that he or she requires 
the reproduction for the purposes of research 
or study. 
The Copyright Act grants the creator of a work 
a number of moral rights, specifically the right of 
attribution, the right against false attribution and 
the right of integrity. 
You may infringe the author’s moral rights if you:
-  fail to acknowledge the author of this thesis if 
you quote sections from the work 
- attribute this thesis to another author 
-  subject this thesis to derogatory treatment 
which may prejudice the author’s reputation
For further information contact the University’s 
Director of Copyright Services
sydney.edu.au/copyright
  
1 
 
 
 
 
 
Nutrition and Gastrointestinal Cancer Risk- 
A study of individual food groups 
 
Genevieve Tse 
  
 
A thesis submitted in fulfillment of 
the requirements for the degree of 
 
Master of Philosophy (Medicine) 
 
 
 
 
 
 
Department of Medicine 
The University of Sydney © 
June 2014 
  
2 
 
Statement of Originality 
 
The contents of this thesis represents original research undertaken by the author from the 
Whiteley-Martin Research Centre, Sydney Medical Program, University of Sydney, Australia. 
 
The author was responsible for the design, development and conduct of the work which was 
performed under the supervision of Associate Professor Guy Eslick. 
 
All literature searches, data extraction and interpretation were completed by the author 
unless otherwise acknowledged. Data analysis was completed by the Associate Professor 
Guy Eslick in conjunction with the author. 
  
3 
 
Certification 
 
 
I hereby certify that the work embodied in this thesis is the result of original research and 
has not been submitted for a higher degree to any other University or Institution. 
 
 
 
________________________________ 
Genevieve Tse 
  
4 
 
Publications 
The following manuscripts have been published, accepted for publication or submitted for 
publication from the work embodied in this thesis. 
 
Journal Papers 
Tse G, Eslick GD. (2014). Cruciferous vegetables and risk of colorectal neoplasms: a 
systematic review and meta-analysis. Nutrition and Cancer, 66 (1): 128-139   
 
Tse G, Eslick GD. (2014) Egg consumption and risk of GI neoplasms: dose-response meta-
analysis and systematic review. European Journal of Nutrition, [Epub ahead of print] 
 
 
 
  
5 
 
Acknowledgments 
First and foremost I would like to thank God for the wisdom and perseverance that he has 
been bestowed upon me during this research, and indeed, throughout my life. 
 
I would like to express my sincere gratitude to my advisor Associate Professor Guy Eslick for 
giving me this research opportunity, for his supervision and continuous support over the 
past several years. His wealth of knowledge, motivation, patience and sense of humor 
created a relaxed yet productive and enjoyable working environment.  
 
I would like to thank my friends and family for their ongoing support, encouragement and 
prayers. Many thanks to Joon Kwon, my significant other, whose continual love and 
encouragement gave me enough motivation to bringing this project to completion.  
 
 
 
 
 
 
 
 
 
 
 
  
  
  
6 
 
Contents 
Statement of Originality 
Certification 
Publications 
Acknowledgements 
Contents 
Abstract 
Introduction 
1. Cruciferous vegetables and Colorectal Cancer Risk 
1.1. Introduction 
1.2. Methods 
1.3. Results 
1.4. Discussion 
2. Soy and Dietary Isoflavones and Gastrointestinal Cancer Risk 
2.1. Introduction 
2.2. Methods 
2.3. Results 
2.4. Discussion 
3. Eggs and Gastrointestinal Cancer risk 
3.1. Introduction 
3.2. Methods 
3.3. Results 
3.4. Discussion 
4. Summary 
5. References 
  
  
7 
 
Abstract 
Diet is an important environmental and modifiable risk factor in gastrointestinal (GI) cancer 
prevention. Epidemiological evidence suggest a protective effect of food such as vegetables 
and fruits, and an increased risk with certain foods of animal origin. However, with a vast 
array of different nutrients within broad categories of food groups, the precise mechanisms 
underlying an association have yet to be determined. This warrants a more detailed 
investigation of individual food types to isolate and identify contributing factors. The 
purpose of this study is to examine the effects of three commonly consumed food types, (1) 
cruciferous vegetables, (2) soy, and (3) eggs on GI cancer risk. As the evidence on these 
foods have been limited and controversial, clarification through meta-analyses and 
systematic reviews would enable further understanding of potential relationships.  
 
A comprehensive database search was completed with MEDLINE, EMBASE, PubMed and 
Current Contents Connect with additional cross checking of reference lists.  Inclusion criteria 
depended on the risk factor investigated but general requirements included the use of 
original data and reporting of an odds ratio or relative risk ratio, and 95% confidence 
interval. Pooled adjusted odds ratios (ORs) comparing highest and lowest categories of 
dietary pattern scores were calculated using a random effects model. Subgroup and 
sensitivity analyses were carried out when warranted to determine the impact of modifying 
variables. 
 
The results of this study identified a decrease in risk of cruciferous vegetable consumption 
and colon cancer (OR, 0.84; 95% CI: 0.72-0.98), with broccoli having a stronger association 
(OR, 0.80; 95% CI, 0.65-0.99). Subgroup analysis on genetic polymorphism identified 
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reduction in risk certain genotypes. Dietary isoflavone is associated with a statistically 
significant risk reduction in GI cancers (OR, 0.73; 95% CI: 0.59-0.92), in particular with 
colorectal cancers (CRC) (OR 0.76, 95% CI: 0.59-0.98). Eggs is associated with a slight 
increase in risk (OR, 1.15;95% CI: 1.09-1.22) with a positive dose-response, the OR for an 
intake of low vs high intake were 1.14 (95% CI: 1.07-1.22; p-value heterogeneity =0.38) and 
1.25 (95% CI: 1.14-1.38; p-value heterogeneity =0.25) respectively.  
 
In conclusion, this study provides evidence to support a protective effect of cruciferous 
vegetable and soy consumption, as well as an increased risk with egg consumption on GI 
cancer development.  
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Introduction 
GI cancer is one of the most common forms of neoplastic diseases worldwide and is 
responsible for substantial morbidity and mortality. The incidence of GI cancer varies greatly 
amongst various peoples. CRC is common in most Western countries; by contrast, there is a 
higher incidence of stomach cancers in China (38%), Korea, South American countries and 
Japan [1]. Migration studies demonstrate a greater lifetime incidence of GI cancer among 
immigrants to high-incidence, industrialized countries compared to residents remaining in 
low-incidence countries [2]. These observations, along with investigations of differences in 
cancer rates and diet between countries have implicated dietaryfactors as playing an 
important role in cancer risk 
 
The evidence linking nutritional factors to cancer is derived from many different lines of 
data of varying strengths. Information on the role of nutrition in the etiology of cancer is 
usually derived from carcinogenicity experiments on animals, in vitro mutagenicity 
experiments in bacterial and mammalian cell lines and epidemiological studies among 
humans. Studies have consistently shown that foods such as vegetables and fruit, which 
contain an abundant array of recognized nutrients and phytochemicals, are associated with 
a reduction in the development of cancers of the GI tract [3]. In 2007, an international 
review panel (World Cancer Research Fund–American Institute for Cancer Research) 
concluded that there was probable evidence that high intake of vegetables decreases the 
risk of cancers of the mouth and pharynx, esophagus, stomach, colon, and rectum. Diets 
high in red and processed meat are strongly associated with an increased risk of colorectal 
cancers [4]. The results of these studies, however, must be interpreted cautiously because 
of intercorrelations amongst different dietary substances. Fruits and vegetables as well as 
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food products of animal origin have very varied composition, consequently it has been 
difficult to sort out the independent effects of specific nutrients or food types among a 
myriad of potential confounders. As such, investigations on specific food types rather than 
broad food groups would be helpful in determining the nutritional components that 
underlie potential protective or harmful effects towards GI cancer development. While it is 
difficult to separate the effects of single foods given the complexity of dietary patterns, 
grouping food types with similar nutrient composition and adjusting for confounding factors 
would help identify any underlying association. 
 
In recent years, several food groups have gained growing interest among the scientific 
community in relation to cancer research. These include cruciferous vegetables, soy foods 
and eggs. These food groups are commonly consumed amongst developed and developing 
countries. A potential effect on the GI tract has been investigated in primary studies, 
however, consensus is yet to be reached on the impact they have on GI cancer risk.  
 
The first part of this study examines the effects of cruciferous vegetable consumption and 
colorectal cancer risk. Vegetables within the cruciferae family, which include broccoli, 
cabbage and brussel sprouts, contain phytochemicals such as carotenoids, vitamin C, fibre 
and flavonoids, and are uniquely rich sources of glucosinolates. Glucosinolates are 
implicated in a number of chemoprotective pathways such as inhibition of carcinogen-
activating enzymes, detoxification of carcinogens, induction of apoptosis and arrest of cell 
cycle progression [5]. One systematic review reported that the majority (67%) of 87 case-
control studies showed an inverse association between consumption of at least one or more 
cruciferous vegetables and cancer risk, the correlation was strongest for cancers of the lung 
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and GI tract [6]. Results from several large prospective cohort studies, suggest that the 
relationship may be complicated by genetic variation as well as the specific type and 
amount of cruiciferae consumed.  
 
The second part of this paper investigates the role of soy as another type of vegetable group. 
Studies on soy consumption and cancer risk have mainly focused on breast and prostate 
cancers, which are hormonally mediated. This is because soy is a rich natural source of 
isoflavone, which has structural and metabolic similarities to mammalian estrogens [7]. A 
number of epidemiological studies and laboratory investigations have suggested that CRC is 
hormone sensitive which has implications of the protective role of isoflavones. A recent 
meta-analysis on soy consumption and colorectal cancer risk found a 21% risk reduction in 
women, however, the overall analysis showed no significant association [8]. Soy also 
contains a number of other phytochemicals and anti-oxidative properties that may 
potentially reduce the risk for non-hormonally mediated cancers. Two separate meta-
analyses suggested an inverse association with stomach cancer, but this may depend on the 
preparation method of soy, with non-fermented products being associated with a greater 
risk reduction [9, 10].   
 
Finally, the effect of eggs consumption is examined. Eggs provide roughly 1.2 per cent of 
available food energy worldwide, contributing a significant portion of dietary cholesterol, 
protein, minerals, folate and B group vitamins [11].  Previous studies have suggested that 
eggs promote colorectal carcinogenesis due to their high cholesterol content [12]. Egg yolk 
was also shown to increase the frequency of  gall-bladder  contraction  and  subsequent 
exposure  of  bile  acids  which are potential carcinogens in GI cancer [13]. The only 
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systematic review on this topic to date reported that over 70% of the 15 studies on egg 
consumption and CRC showed an increased risk [12]. Some studies also suggested an 
increased risk of esophageal and gastric cancers [14-18]. Epidemiological studies have 
yielded conflicting and controversial results, although a positive, insignificant relation was 
found in most studies. 
 
Understanding the role of environmental factors in GI carcinogenesis may inform additional 
primary prevention strategies that can further reduce risk. This overview summarises the 
epidemiological evidence on the association of three commonly consumed food groups, (1) 
cruciferous vegetables, (2) soy and (3) eggs, and GI cancer risk. A careful review of the data 
is provided and this includes quantitative meta-analyses of the primary studies, updating 
any prior reviews and completing subgroup analyses wherever possible to further 
investigate the etiology of GI cancer. The difficulties in investigating this topic and 
possibilities for further research are then discussed. 
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Chapter One 
Cruciferous vegetables and Colorectal Cancer Risk 
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1.1 Introduction 
Recently, consumption  of  vegetables  of  the  family  cruciferae, rather than vegetables as a 
group, have drawn a great deal of attention in cancer research because of their potential 
protective properties [19]. The most commonly  consumed  group  of cruciferous vegetables 
in the Western diet are vegetables of the brassica  genus, these include cabbage, brussel 
sprouts, and broccoli [20].  
 
Like other vegetables, cruciferous vegetables contain a number of phytochemicals with 
potential cancer chemopreventive properties, including carotenoids, vitamin C, and 
flavonoids. However, what makes them unique is that they are rich sources of 
glucosinolates [21]. The breakdown of plant cells triggers the enzymatic myrosinase activity, 
which hydrolyzes glucosinolates into the biologically active compound ITC. ITCs exert their 
protective effects via multiple mechanisms, including inhibition of carcinogen-activating 
enzymes, inhibition of angiogenesis, detoxification of carcinogens, induction of apoptosis 
and arrest of cell cycle progression [5].  
 
Based on our understanding, we expect to see an inverse association between cruciferous 
vegetable intake and the risk of developing colorectal neoplasms. However, the data 
accumulated to date has been weak and inconsistent. Results of large prospective cohort 
studies and case-control studies taking into account individual genetic variation suggest that 
the relationship may be complicated by genetics, in particular polymorphism of GTS, a phase 
II conjugating enzyme [22]. 
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GSTs are important in metabolizing isothiocyanates (ITC), hence, the  protective  effect  of  
cruciferous vegetables may predicate on GST genotype [22]. GSTM1 and GSTT1 are the two 
variants most frequently studied [23]. One hypothesis is that individuals with the null 
genotype of the GSTM1 or GSTT1 polymorphism would less readily conjugate and excrete 
ITCs, and hence would experience a greater protective effect against colorectal neoplasm 
development [24]. Such effect has been observed among individuals who were null for both 
GSTM1 and/or GSTT1 colo-rectum, lung and breast. However, a recent meta-analysis 
showed that null genotypes conferred additional risk for colorectal cancer in Caucasian 
populations [25]. The type of cruciferae consumed may also influence the protective 
outcome against developing colorectal neoplasms. Certain cruciferae, broccoli for example, 
contain much greater amounts of glucosinolate, exposing the individual to higher levels of 
ITC and therefore may provide greater anti-carcinogenic benefits [23, 26]. Cohort studies 
that have examined vegetable subgroups have found protective benefits with broccoli [27]. 
Site specific differences have also been reported when comparing the different parts of the 
colorectal tract. No systematic reviews however, have previously been conducted to 
thoroughly unify this information and assess this evidence. 
 This systematic review and meta-analysis aims to summarize epidemiological 
findings to investigate the relationship between cruciferous vegetable intake and colorectal 
neoplasm risk, including the influence of individual genetic variation of the GSTM1 and 
GSTT1 genes as well as the specific type of cruciferae consumed.  
 
 
 
1.2 Methods 
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Study Protocol 
Literature searches of epidemiological studies in this systematic review were performed 
using the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines 
where possible [28]. The following electronic databases were searched: Medline, PubMed, 
ISI Web of Science, Current Contents Connect and Embase. The search included all studies 
published up to August 5, 2012. Key terms including ‘Cruciferous vegetables’ OR ‘Brassica 
vegetables’ AND ‘Colorectal neoplasm’ were searched as text words and as exploded 
medical subject headings where possible. References in the relevant review articles from 
the bibliographic database search were also checked for appropriate studies. No language 
restrictions were used in either the search or study selection.  A search for unpublished 
literature was not performed.  
Study Selection 
The following inclusion criteria was applied in the screening of articles: (1) original data was 
provided; (2) the association between cruciferous vegetable intake and colorectal neoplasm 
risk was addressed; (3) the risk point estimate was reported as an odds ratio (OR) or relative 
risk (RR), or the data was presented such that an OR could be calculated; (4) the 95% 
confidence interval (CI) was reported, or the data was presented such that the CI could be 
calculated. Studies which did not meet the inclusion criteria were excluded. 
Data Extraction 
Data was performed via a standardized data extraction form, collecting information on the 
publication year, study design, number of cases and controls, total sample size, temporal 
direction, population type, country, ethnicity of sample group, economic development, case 
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control matching, mean age, response rate, exposure, neoplasm type, number of adjusted 
variables, the risk estimates or data used to calculate the risk estimates, CIs. Quality of the 
studies was not assessed and authors were not contacted for missing data. Adjusted odds 
ratios were extracted in preference to non-adjusted odds ratios, however, where odds 
ratios were not provided, unadjusted ORs and CIs were calculated. Where more than one 
adjusted ratio was reported, the ratio with the highest number of adjusted variables was 
chosen. Where multiple risk estimates were available in the same study, for example due to 
the use of  mutually exclusive comparator groups, they were included as separate risk 
estimates. Where ORs were provided in tertiles, quantiles or quintiles, the middle tiles were 
included. 
Statistical Analysis 
Pooled odds ratios and 95% confidence intervals were calculated for the effect of 
cruciferous vegetable intake on the risk of colonic neoplasms using a random effects model, 
model of DerSimmonian and Laird [29]. Heterogeneity with Cochran’s Q statistic was tested, 
with P<0.10 indicating heterogeneity, and the degree of heterogeneity was quantified using 
the I
2
 statistic, which represents the percentage of the total variability across studies due to 
heterogeneity. I
2 values of 25, 50 and 75% corresponded to low, moderate and high degrees 
of heterogeneity respectively [30]. Publication bias was quantified using the Egger’s 
regression model [31]. All analyses were performed with Comprehensive Meta-analysis 
(version 2.0). 
 
 
1.3 Results 
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Literature search 
The literature searches identified 416 articles for evaluation. Of these, 33 articles were 
eligible for inclusion. Exclusion reasons for the remainder included: original epidemiological 
data on the association between cruciferous vegetable intake and colorectal neoplasm risk 
was not provided; risk estimates could not be obtained; CIs were not provided and could not 
be calculated; only abstract was available. Of the 33 studies included in the final meta-
analyses, 29 studies reported on total cruciferous vegetable intake. 2 subgroup analyses 
were developed: 8 studies reported on intake of individual cruciferous vegetables, 8 studies 
examined the effect of gene variant of the GST gene on cruciferous vegetable intake and 
colorectal neoplasm risk outcome (Figure 1.1). Egger’s regression analysis for assessment of 
publication bias of the studies included in this meta-analysis found no significant bias 
(p=0.13) (Figure 1.2). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Flow chart of the study selection process 
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Figure 1.2 Funnel plot showing studies assessed for publication bias of total cruciferous 
vegetable intake 
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Association between total cruciferous intake and colorectal neoplasm 
There were 11 prospective cohort studies and 18 case-control studies, representing a total 
of 5994 colorectal cancers, 5370 colon cancers, 1900 rectal cancers, and 814 colonic 
adenoma cases (Table 1.1). Only colon cancer showed a significant association with total 
cruciferous vegetable intake (OR, 0.84; 95% CI: 0.72-0.98; p-value heterogeneity <0.001; I2 = 
64.44) (Figure 1.3), with moderate heterogeneity. Additional analysis for colorectal cancer, 
colonic adenoma and rectal cancer all produced no significant association with total 
cruciferous vegetable intake (OR, 0.92; 95% CI: 0.83-1.01; p-value heterogeneity <0.001; I2 = 
66.16%), (OR, 1.09; 95% CI: 0.90-1.33; p-value heterogeneity 0.39; I2 = 0.00%), (OR, 0.99; 
95% CI: 0.67-1.46; p-value heterogeneity <0.001; I2 =87.16%), respectively. 
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Reference Country Ethnic 
group 
Study 
design 
Study 
population 
Neoplasm 
type 
Case/ 
Control 
size 
Cohort 
size 
Type of dietary 
assessment 
Young 1988 [32] USA Caucasian Case-control  Population Colon 353/618  FFQ
 
Lee 1989 [33] Singapore Asian Case-control  Hospital CRC
 
101/212  Interview, FFQ 
West 1989 [34] USA Caucasian Case-control  Population-
Women 
Colon 112/185  Interview 
Peters 1992 [35] USA Caucasian Case-control  Population Colon 746/746  Interview, FFQ 
Bidoli 1992 [36] Italy Caucasian Case-control  Hospital Colon, Rectal  54/460  Interview 
 
Steinmetz 1993 [37] Australia Caucasian Case-control  Population-
Men 
Colon 55/109  FFQ 
Steinmetz 1994 [12] USA Caucasian Cohort Population-
Women 
Colon 212 41837 Questionnaire 
Freedman 1996 [38] USA Caucasian Case-control  Hospital CRC 41/80  FFQ 
 
Lin 1998 [39] USA Caucasian Case-control  Hospital CR adenoma 114/116  FFQ 
Hsing 1998 [40] USA Caucasian Cohort Population-
Men 
CRC  47 17663 Questionnaire 
Sellers 1998 [41] USA Caucasian Cohort Population-
Women 
Colon 63 35216 FFQ 
Franceschi 1998 [42] Italy Caucasian Case-control Hospital Colon, Rectal 1225/376  Interview, FFQ 
Pietinen 1999 [43] Finland Caucasian Cohort Population-
Men smokers 
CRC 42 27111 Questionnaire 
 
Voorrips 2000 [44] Netherlands Caucasian Cohort Population Colon 910 120816 Questionnaire 
 
Michels 2000 [45] USA Caucasian Cohort Population-
health 
Colon, Rectal 1181 
 
136089 Questionnaire 
 
Table 1. Characteristics of studies reporting odd ratios and 95% CIs for the association between total cruciferous vegetable 
intake and colorectal neoplasm risk 
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workers 
Seow 2002 [22] Singapore Asian Cohort Population CRC 86/595  Interview, FFQ 
Seow 2002 [46] Singapore Asian Case-control Hospital CRC 90/154  Interview, FFQ 
Hara 2003 [47] Japan Asian Case-control  Hospital CRC 29/70  FFQ 
McCollough 2003 [48] USA Caucasian Cohort Population Colon 508 133163 FFQ 
Chiu 2003 [49] China Asian Case-control  Population Colon 232/388  Interview, FFQ 
Turner 2004 [50] UK Caucasian Case-control  Population CRC 103/174  Interview 
Tijhuis 2005 [51] Netherlands Caucasian Case-control  Hospital CR adenoma 410/349  FFQ 
Michels 2006 [52] USA Caucasian Cohort Population- 
Health 
workers 
CR adenoma 255/5199  Questionnaire 
Hu 2007 [53] Canada Caucasian Case-control  Population Rectal  576/1277  Questionnaire 
Hu 2007 [54] Canada Caucasian Case-control  Population Colon 196/715  Questionnaire 
Moy 2008 [55] China Asian Cohort Population CRC 54/280  Interview 
Epplein 2009 [56] USA Multiethnic Cohort Population CRC 134/256  FFQ 
Ramadas 2009 [57] Malaysia Asian Case-control Hospital CR adenoma 35/44  FFQ 
Yang 2010 [58] China Asian Case-control  Population CRC 209/826  FFQ 
         
a: Abbreviations are as follows: CRC, Colorectal Cancer; FFQ, Food-frequency Questionnaire 
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Figure 1.3 Forest plot of total cruciferous vegetable consumption and colon cancer risk  
 
Analysis of additional variables including country, gender, ethnicity, study population, 
vegetable assessment method, study design and direction were conducted (Table 1.2). All 
other factors were not statistically significant. 
 
Table 1.2 Odd ratios and 95% CIs for additional variables examined for the association 
between total cruciferous vegetable intake and colorectal neoplasm risk 
 
Factor OR (95% CI) 
Ethnicity  
Asian 0.92 (0.76-1.11) 
Caucasian 0.93 (0.83-1.04) 
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Study Design  
Cohort 0.92 (0.76-1.12) 
Case Control 0.91 (0.8-1.03) 
Temporal Direction  
Prospective 0.92 (0.76-1.12) 
Retrospective 0.91 (0.8-1.03) 
Population type  
Population 0.87 (0.74-1.02) 
Hospital 0.83 (0.65-1.07) 
Population gender  
Male 0.85 (0.67-1.08) 
Female 1.09 (0.75-1.59) 
Method of assessment for vegetable 
intake 
 
Interview 0.92 (0.78-1.09) 
Self-administered questionnaire 0.98 (0.81-1.20) 
Food-frequency questionnaire 0.86 (0.74-1.01) 
Neoplasm type  
Colon 0.84 (0.72-0.98)1 
Rectal 0.99 (0.67-1.46) 
Colorectal 0.89 (0.77-1.03) 
Adenoma 1.09 (0.9-1.33) 
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Results stratified by individual cruciferous vegetables 
2 cohort and 6 case-control studies investigated the association between intake of 
individual cruciferous vegetable types and colonic tumor risk (Table 1.3).  
Table 1.3 Characteristics of studies reporting odd ratios and 95% CIs for the association 
between individual cruciferous vegetable intake and colorectal neoplasm riska 
 
Reference Country Ethnic 
group 
Study 
design 
Study 
population 
Neoplasm 
type 
Exposure Case/ 
Control 
size 
Cohort 
size 
Young 1988 [32] USA Caucasian Case-
control  
Population Colon Cabbage 353/618  
Steinmetz 1993 [37] Australia Caucasian Case-
control  
Population-
Men 
Colon Broccoli, 
brussel 
sprouts 
cabbage 
110/218  
Steinmetz 1994 [59] USA Caucasian Cohort Population-
Women 
Colon Broccoli, 
brussel 
sprouts, 
cabbage 
159 41873 
Lin 1998 [39] USA Caucasian Case-
control  
Hospital CR 
adenoma 
Broccoli, 
cabbage 
299/374  
Slattery 2000 [60] USA Caucasian Case-
control  
Population Colon Broccoli, 
brussel 
sprouts, 
cabbage 
301/326  
Flood 2002 [27] USA Caucasian Cohort Population-
Women 
CRC Broccoli 97/9098 45490 
Evans 2002 [61] UK Caucasian Case-
control 
Population CRC Broccoli 512/512  
Hara 2003 [47] Japan Asian Case-
control  
Hospital CRC Broccoli, 
cabbage 
81/2110  
a: Abbreviations are as follows: CR, Colorectal; CRC, Colorectal Cancer 
 
Data for broccoli and cabbage was provided in 7 of the studies, brussel sprouts was reported 
in 3 studies. Broccoli and cabbage were inversely associated with colonic tumor risk while 
brussel sprouts showed no such association. In the data generated, the pooled odds ratios 
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for CRC cancer risk comparing the highest versus lowest categories of intake were 0.80 (95% 
CI, 0.65-0.99; p-value heterogeneity = 0.02; I2= 56.16%) for broccoli (Figure 1.4), 0.95 (95% 
CI, 0.80-1.14; p-value heterogeneity= 0.34; I2= 11%) for cabbage and 1.00 for brussel sprouts 
(95% CI, 0.75-1.34, p-value heterogeneity=0.83, I2=0%). Only broccoli intake showed 
statistically significant inverse association with colonic tumor risk.  
 
Figure 1.4 Forest plot of broccoli consumption and colorectal neoplasm risk   
 
 
 
Results stratified by GST genotypes 
2 prospective cohort studies and 6 case-control studies, examined GST-diet interaction  and  
thus  estimates  for  the  association between dietary ITCs and colonic tumor risk (Table1.4).  
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Reference Country Ethnicity Study 
design 
Population Disease 
type 
Exposure Genes assessed Case/Control 
number 
Cohort 
number 
Type of 
dietary 
assessment 
Lin 1998 
[39] 
 
USA Caucasian Case-control  Hospital CR 
adenoma 
Cruciferous 
vegetables 
GSTM1 null 
GSTM1 non-null 
67/85 
67/67 
 FFQ 
Slattery 
2000 [60] 
USA Caucasian Case-control  Population Colon Broccoli GSTM1 null 
GSTM1 non-null 
165/161326/627 
136/165 
 Interview 
Lin 2002 
[62] 
 
USA Caucasian Case-control  Hospital CR 
adenoma 
Cruciferous 
vegetables 
 
GSTT1 null 
GSTT1 non-null 
GSTM1+GSTT1 
non-null 
GSTM1/GSTTI 
null 
  
35/54 
156/225 
105/114 
86/165 
 Interview 
Seow 2002 
[22] 
Singapore Asian Cohort Population CRC Cruciferous 
vegetables 
(Dietary ITC) 
GSTM1,  
GSTT1 
86/594 
86/594 
 
63257 Interview,FFQ 
 
Turner 
2004 [50] 
UK Caucasian Case-control  Population CRC Cruciferous 
vegetables 
GSTM1 null, 
GSTM1 non-null  
GSTT1 null 
GSTT1 non-null 
GSTM1+GSTT1 
non-null 
GSTM1/GSTT1 
null 
103/96 
103/96 
125/185 
125/185 
125/185 
125/185 
 Questionnaire 
Tijhuis 
2005 [51] 
Netherlands Caucasian Case-control  Hospital CR 
adenoma 
Cruciferous 
vegetables 
 
GSTM1 null 
 
213/192 
 FFQ 
Table 1.4 
Characteristics of studies reporting odd ratios and 95% CIs for the association between individual cruciferous vegetable intake and 
colorectal neoplasm risk with stratification by GST genotype 
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GSTM1 non-null 
GSTT1 null 
GSTT1 non-null 
GSTM1+GSTT1 
null 
GSTM1+GSTT1 
non-null 
GSTM1/GSTT1 
null 
194/157 
71/66 
336/283 
32/36 
155/127 
220/186 
Epplein 
2009 [56] 
USA Multiethnic Cohort Population CRC Urinary ITC 
levels 
GSTM1 null,  
GSTT1non-null 
91/147 
46/122 
67594 FFQ 
Yang 2010 
[58] 
China Asian Case-control  Population-
women 
CRC Cruciferous 
vegetables, 
urinary ITC 
levels 
GSTM1 null 
GSTM1 non-null 
GSTT1 null 
GSTT1 non-null 
GSTM1+GSTT1 
null 
GSTM1+GSTT1 
non-null 
GSTM1/GSTT1 
null 
 
95/379 
84/307 
87/352 
92/334 
69/256 
66/211 
81/356 
 FFQ, Urinary 
ITC 
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These 8 studies, representing 1777 colorectal cancer and 1546 adenoma cases, reported on 
the association between cruciferous vegetable consumption and colonic tumor risk 
stratified by GSTM1 and GSTT1 genotypes. Cruciferous vegetable consumption was 
measured by food-frequency questionnaire (FFQ) or dietary questionnaire in 6 studies, with 
one study measuring intake using urinary ITC levels. Analysis of variables including country, 
gender, ethnicity, study population, vegetable assessment method, study design and 
direction were conducted (Table 1.5).The only significant findings were for the GSTT1 null 
gene which produced an odds ratio of 0.78 (95% CI: 0.64-0.95; p-value heterogeneity 0.32; I2 
= 13.67).  
 
Table 1.5 
Odd ratios and 95% CIs for additional variables examined for the association between 
cruciferous vegetable intake and colorectal neoplasm risk with stratification by GST 
genotype 
 
Factor OR (95% CI) 
Ethnicity  
Asian 0.91 (0.82-1.01) 
Caucasian 0.98 (0.90-1.08) 
Study Design  
Cohort 0.90 (0.74-1.09) 
Case Control 0.97 (0.90-1.04) 
Temporal Direction  
Prospective 0.90 (0.74-1.09) 
Retrospective 0.97 (0.90-1.04) 
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Population type  
Population 0.96 (0.87-1.06) 
Hospital 0.97 (0.84-1.11) 
Population gender  
Female 0.91 (0.80-1.04) 
Neoplasm type  
Colon 1.06 (0.9-1.26) 
 
CRC 0.92 (0.84-1.01) 
Adenoma 0.97 (0.84-1.11) 
Gene status  
GSTM1 null 1.05 (0.92-1.19) 
GSTM1 non-null 1.02 (0.92-1.13) 
GSTT1 null 0.78 (0.64-0.95)a 
GSTT1 non-null 1.02 (0.90-1.13) 
GSTM1, GSTT1 double null 0.86 (0.70-1.06) 
GSTM1, GSTT1 double non-null 1.11 (0.86-1.43) 
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1.4 Discussion  
Epidemiological evidence collated in this systematic review show that there is an inverse 
association between total cruciferous vegetable intake and risk of developing colorectal 
neoplasm. However, such association is not statistically significant, except in the case for 
colon cancers. A comprehensive review of epidemiologic studies published prior to 1996 [6] 
reported that the majority (67%) of 87 case-control studies reported a negative correlation 
between consumption of at least one or more cruciferous vegetables and cancer risk. 
According to the review, the inverse association was most consistent for cancers of the lung 
and gastrointestinal tract.  
 
Much emphasis regarding the anti-carcinogenic properties of cruciferous vegetables is 
placed on its unique source of glucosinolates [26, 63]. Glucosinolates are converted to ITCs 
by the action of a myrosinase [5]. Several experimental studies and animal models support a 
potential anticancer role of ITCs against colorectal cancers [64, 65].  However, most studies 
used in this systematic review do not allow inferences to pinpoint ITCs as the key anti-
carcinogenic constituent of cruciferous vegetables because other nutrients and 
phytochemicals (e.g., flavonols, folate, and carotenoids) found in cruciferous vegetables 
may also contribute to the inverse association with colorectal neoplasm [26]. Only a number 
of studies specifically evaluated the ITC levels in servings of cruciferous vegetables as a 
measure of exposure [22, 66-68]. 
 
Moreover, while this study attempts to analyze cruciferous vegetables as a separate factor, 
the consumption of these individual vegetables is likely positively correlated with the total 
consumption of vegetables in general. In most of the epidemiological studies the effect of 
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cruciferous vegetables was not completely separated from the effect of total vegetables by 
adjusting for the consumption of these vegetables. Studies that measure the intake of 
individual cruciferous vegetables in accordance with their ITC levels may better define the 
benefits of ITC and distinguish protective properties of the cruciferae from other vegetables.   
Amongst the studies that looked at the outcome of consuming individual types of 
cruciferous vegetables, broccoli, cabbage and brussel sprouts were most examined. Intake 
of broccoli in particular showed the strongest evidence (statistically significant) against CRC 
development. A plausible explanation for this is due to broccoli’s high glucosinolate content 
[69]. In a series of laboratory studies, broccoli was found to be rich in phytochemicals that 
induced phase II detoxification enzymes and enhanced antioxidant activities in mammalian 
cells[63, 70, 71]. One serving can contain up to 60 mg of glucoraphanin, a type of 
glucosinolate[26]. Broccoli sprouts in particular contain about 20–100 times more 
glucoraphanin than a full-grown broccoli head [63].  
 
Data from the studies used in this review did not account for the maturity of vegetables 
consumed (young sprouts versus full-grown) nor the preparation methods of these 
vegetables. Such variability may act to undermine the validity of the results. 
 
Inherited differences in the capacity of individuals to metabolize and eliminate glucosinolate 
hydrolysis products have been hypothesized to contribute to differences in the degree of 
protection conferred by cruciferous vegetable intake [72]. GSTs conjugate ITCs to 
glutathione and lead to excretion [26]. Variants of several GST enzymes have been 
described, of which GSTM1 and GSTT1 have been most extensively studied.  Roughly half 
the population lack GSTM1 due to gene deletion [73]. The homozygous deletion of GSTM1 
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gives rise to the null phenotype in which there is no expression of the GSTM1 protein. The 
hypothesis is that individuals with the null genotype of the GSTM1 or GSTT1 polymorphism 
would have less conjugation activity, and thus permitting ITC to remain biologically active 
for a longer period to provide potentially greater protection against cancer [74]. 
 
Previous epidemiological data have been inconsistent and there is little evidence to support 
this theory in the context of colorectal neoplasm risk. A recent comprehensive meta-
analysis have in fact demonstrated increased risk with GSTM1 and GSTT1 null genotypes in 
Caucasian populations [25]. However, results from this study reveal statistically signiﬁcant 
protective effects of cruciferae consumption against colorectal neoplasms among 
individuals with a single null GSTT1 genotype. This discrepancy may be due to the fact that 
the mentioned study did not consider gene-environment interactions which may 
significantly influence the outcome. In which case cruciferous vegetable intake seems play a 
significant role in colorectal cancer risk reduction. 
 
A weakness of the evidence that comprises this systematic review is the measurement error 
that inherently exists when using dietary questionnaires. FFQs employed in epidemiological 
studies query a limited range of food items (thus omitting some sources of ITC), and rely on 
quantifying phytochemical exposure to constituents based on the weight or servings of 
cruciferous vegetable consumed [69]. This approach has limitations in that the difference in 
levels of glucosinolates between different cruciferous vegetables is not accounted for. In 
addition, selection bias and recall bias could have accounted for part of the inverse 
associations observed in many case-control studies, leading to differential reporting. The 
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observed risk estimate for case-control studies was similar to that for cohort studies which 
suggests that in this instance recall bias does not play a prominent role.  
 
While most studies adjusted for age and gender in the calculation of risk estimates, not all 
parameters were considered. A meta-analysis would not adequately adjust for this. As such, 
unadjusted confounders may undermine the association between cruciferous vegetables 
and colorectal neoplasm risk. 
 
Another weakness in the evidence is that the biological potency of cruciferous vegetables 
may differ, depending on cooking practices, because this influences the bioavailability of 
ITCs [75]. Glucosinolates are water-soluble compounds that leach into cooking water. Some 
cooking methods, including boiling, steaming and microwaving at high power can inactivate 
myrosinase, decreasing the bioavailability of ITCs [76-78]. The lack of information about 
cooking methods thus introduces a potential source of heterogeneity in the results. 
 
To address issues relating the specificity of the protective effects attributable to cruciferous 
vegetables, further epidemiological research should pay specific attention to simultaneous 
modeling of different vegetables (or vegetable groups) and adjustment for confounding due 
to other chemoprotective constituents. However, this may be limited as certain constituents 
may be closely linked with other similar food group and would be difficult to adjust for 
 
Based on assessments of cruciferous vegetable intake and measurements of the maximal 
amounts of ITC that can be released, researches have attempted to calculate human ITC 
  
35 
 
exposure [69]. A food composition database may be used to provide a more consistent and 
accurate assessment of dietary ITC intake. 
Since other factors may alter the amount of ITC formed and absorbed, assessing dietary 
intake alone may not accurately measure an individual’s exposure to ITC. Urinary ITC 
measurement was significantly correlated with cruciferae intake derived from two dietary 
assessment approaches [79, 80]. Urinary ITC levels could supplement traditional food 
database data by providing an index of recent cruciferous vegetable intake not susceptible 
to reporting biases. 
 
Whilst there is evidence to support the idea of gene-diet interaction, more research can be 
done to explore the influence of gene polymorphisms other than GST genotypes. Genes 
such as p53 [38] and Ki-ras [81] have been reported to show significant associations with 
cruciferae intake. The study of alternative genetic factors can provide a better 
understanding of the different pathways and mechanisms which underpin cruciferae’s anti-
carcinogenic properties.  
 
In conclusion, intake of cruciferous vegetable is inversely associated with colon cancer risk. 
The consumption of broccoli in particular is demonstrated to be positively correlated with 
protection against colorectal neoplasm development. There is a positive correlation 
between GST polymorphism and the capacity of cruciferous vegetables to exhibit 
chemoprotective properties, in which the GSTT1 null genotype confers a reduction 
colorectal neoplasm development risk. Future epidemiological studies should use food 
databases or urinary ITC levels as methods for more accurate cruciferae intake 
measurements. Individual cruciferae types and preparation methods should be considered 
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during analysis. More research on alternative gene polymorphisms would also be helpful in 
studying gene-diet interactions with cruciferous vegetables.  
 
 
 
 
 
 
 
 
Chapter Two 
Soy and Dietary Isoflavone and  
Gastrointestinal Cancer Risk 
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2.1 Introduction 
Certain food groups such as vegetables and fruits contain phytochemicals with anti-
carcinogenic properties. Soy foods and soybean components, in recent years, have 
particularly received considerable attention for their potential role in reducing cancer risk. 
Although the breast  and  prostate  cancer  has  been  the  focus  of  most  interest, there is 
an expanding body of literature on the possible association  between  soy  foods and 
gastrointestinal (GI) cancers.  
 
A number of anti-carcinogenic phytochemicals in soybeans have been identified, including 
phytosterols, phenolic acids and protease inhibitors[82]. Among these, most attention has 
been focused on the component isoflavones. Isoflavones have a limited distribution in 
nature with soybeans being its main source [83]. Although many investigators have focused 
on its anti-estrogenic properties and its potential for preventing hormonally mediated 
cancers, they also act as antioxidants and possess other anticarcinogenic activities, including 
inhibition of angiogenesis [84], topoisomerase [85], and tyrosine kinase [86]. 
Genistein, one of the predominant isoflavones in soy, has been demonstrated to inhibit 
proliferation of cultured cells, including normal and transformed intestinal epithelial cells in 
a number of rodent and human cancer cell lines [87]. 
 
Whilst the mechanisms that underpin an inverse relation between soy consumption and GI 
cancer risk seem plausible, the evidence from epidemiological data to date has been 
inconsistent and controversial. A recent meta-analysis examining 4 cohort and 9 case-
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control studies on soy consumption and colorectal cancer risk found a 21% risk reduction in 
women, however, the overall analysis showed no significant association [8]. Two separate 
meta-analyses reviewed the effects of soy foods on gastric cancer risk on different 
population groups [9, 10, 82] . Pooled results from their meta-analyses suggested that the 
risk of stomach cancer may depend on whether the soy food was fermented or 
nonfermented, with nonfermeted products being associated with a greater risk reduction.  
Results from in vitro and in vivo animal studies have also been inconsistent with regard to a 
protective effect of soy and colorectal cancers. Five studies showed a statistically  significant  
effect  of  soy  diet or isoflavone supplement inhibiting the formation of aberrant crypt foci 
in rats, which are preneoplastic lesions of colorectal cancer [88]. Three studies that tested 
soy protein isolate on chemically-induced colon cancer did not note a reduction in 
carcinogenesis [89-91].  
 
Previous epidemiological studies have used different parameters in reporting the serving 
sizes and have included different types of soy in their analysis, making interpretation of 
results difficult. Gender influence has also been an area of interest given the antiestrogenic 
properties of soy isoflavone. This systematic review and meta-analysis aims to summarize 
epidemiological findings to explore and clarify the relationship between soy intake and 
gastrointestinal cancer, including subgroup analyses of dietary isoflavone intake, anatomical 
subsites, the influence of gender and types of soy food consumed.  
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2.2 Methods 
Study Protocol 
Literature searches of epidemiological studies in this systematic review were performed 
using the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines 
where possible [92]. The following electronic databases were searched: Medline, PubMed, 
ISI Web of Science, Current Contents Connect and Embase. The search included all studies 
published up to May 27, 2014. Key terms including ‘Soy’ OR ‘Isoflavone’ AND 
‘Gastrointetinal neoplasm’ were searched as text words and as exploded medical subject 
headings where possible. References in the relevant review articles from the bibliographic 
database search were also checked for appropriate studies. No language restrictions were 
used in either the search or study selection.  A search for unpublished literature was not 
performed.  
Study Selection 
The following inclusion criteria was applied in the screening of articles: (1) original data on 
soy consumption and GI neoplasms risk, that of the esophagus, stomach and/or colorectum, 
was provided; (2) the risk point estimate was reported as OR or RR, or the data was 
presented such that an OR could be calculated; (3) the 95% confidence interval (CI) was 
reported, or the data was presented such that the CI could be calculated. 
Data Extraction 
Data was performed via a standardized data extraction form, collecting information on the 
publication year, study design, number of cases and controls, total sample size, temporal 
direction, population type, country, ethnicity of sample group, case control matching, mean 
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age, response rate, exposure, neoplasm type, number of adjusted variables, the risk 
estimates or data used to calculate the risk estimates, CIs. Quality of the studies was not 
assessed and authors were not contacted for missing data. Adjusted odds ratios were 
extracted in preference to non-adjusted odds ratios, however, where odds ratios were not 
provided, unadjusted ORs and CIs were calculated. Where more than one adjusted ratio was 
reported, the ratio with the highest number of adjusted variables was chosen. Where 
multiple risk estimates were available in the same study, for example due to the use of  
mutually exclusive comparator groups, they were included as separate risk estimates. 
Where ORs were provided in tertiles, quantiles or quintiles, the middle tiles were included. 
Statistical Analysis 
Pooled odds ratios and 95% confidence intervals were calculated for the effect of soy intake 
on the risk of GI neoplasms using a random effects model, model of DerSimmonian and 
Laird [93]. Heterogeneity with Cochran’s Q statistic was tested, with P<0.10 indicating 
heterogeneity, and the degree of heterogeneity was quantified using the I
2
 statistic, which 
represents the percentage of the total variability across studies due to heterogeneity. I
2 
values of 25, 50 and 75% corresponded to low, moderate and high degrees of heterogeneity 
respectively [94]. Publication bias was quantified using the Egger’s regression model [31]. All 
analyses were performed with Comprehensive Meta-analysis (version 2.0). 
Effect modification was tested between soy intake and other covariates (country, gender, GI 
site, specific soy foods and method of soy preparation) through the addition of 
multiplicative interaction terms into the model. A separate analysis for dietary isoflavone 
intake and GI cancer risk was performed. As different methods were used to report soy 
intake, sensitivity analysis on serving sizes involved categorizing studies using a standardized 
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measurement- consumption of 3 or more times per week, and excluding those that did not 
specify intake frequency. 
  
2.3 Results 
The literature searches identified 348 articles for evaluation. Title and abstract screening 
excluded 292 articles due to duplicates, non-human or non-original research. Full text 
screening excluded 15 articles- 7 studies did not include soy or isoflavone in the dietary 
assessment, confidence intervals could not be calculated in 6 studies, and 2 studies did not 
present original data. 23 case-control and 18 cohort studies were included in the final meta-
analysis, which contained a total of 633,476 participants and 13,639 GI cancer cases. 
Characteristics of studies are outlined in Table 2.1. 
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Table 2.1 Characteristics of included case-control and cohort studies reporting odd ratios and 95% CIs for the association between 
soy/isoflavone intake and GI neoplasm risk 
 
Reference Location Group Type of Neoplasm Soy Intake Serving 
Sizes 
Total Cases/ 
Controls  
OR 
Case Control Studies 
Hu 1988 [95] 
 
China Hospital Gastric cancer Fermented soy N/A 77/100 1.51 (1.02-2.23) 
Kono 1988 [96] 
 
Japan Hospital Colorectal adenoma Miso ≥ 2/day 
 
38/347 0.87 (0.55-1.37) 
You 1988 [97] China Population Gastric cancer Soy > 5 kg/year 
 
141/282 0.60 (0.40-0.80) 
Kato 1990 [98] Japan Population Gastric cancer Miso ≥ 2/day M: 148/623 
F: 69/883 
1.04 (0.60-1.81) 
0.83 (0.44-1.58) 
Hu 1991 [99] China Hospital Rectal cancer Fermented soy High 116/116 (Male) 3.07 (1.22-7.72) 
Hoshiyama 1992 [100] 
 
Japan Hospital 
Population 
Gastric cancer 
 
Soy ≥ 8/wk 
 
147/147 
147/101 
 
0.80 (0.40-1.40) 
0.60 (0.40-1.00) 
Hoshiyama 1993 [101] 
 
Japan Population Colon cancer 
 
Rectal cancer 
Soy 
Miso 
Soy 
Miso 
≥ 8/wk 
≥ 2/day 
36/163 
36/163 
51/163 
51/163 
0.60 (0.30-1.30) 
1.90 (0.80-4.40) 
0.40 (0.20-0.90) 
0.80 (0.40-1.60) 
Inoue 1994 [102] 
 
Japan Hospital Gastric cancer Miso 
Tofu 
≥ 3/wk 
 
13/133 
133/133 
0.95 (0.75-1.20) 
0.89 (0.71-1.11) 
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Inoue 1995 [103] 
 
Japan Hospital Colon cancer (Proximal, 
distal) 
 
 
Rectal cancer 
Soy 
 
Miso 
 
Soy 
 
Miso 
≥ 3/wk 
 
125/4025 (Male) 
103/6292 (Female) 
125/6981 (Male) 
103/6292 (Female) 
131/4025(Male) 
70/4905 (Female) 
131/6981 (Male) 
70/6292 (Female) 
0.90 (0.50-1.60) 
1.30 (0.70-2.40) 
1.20 (0.60-2.20) 
0.80 (0.40-1.00) 
1.20 (0.80-1.70) 
0.90 (0.60-1.50) 
0.80 (0.60-1.20) 
1.10 (0.70-1.80) 
Lee 1995 [104] 
 
Korea Hospital Gastric cancer Soy 
Miso 
≥ 2/wk 
 
54/68 
191/97 
0.20 (0.10-0.80) 
5.50 (2.50-12.1) 
Marchand 1997 [105] USA Population CRC Soy ≥ 25 g/day 
 
174/174 (Male) 
123/123 (Female) 
1.00 (0.60-1.60) 
0.90 (0.50-1.50) 
Nishi 1997 [106] 
 
Japan Population Colon cancer 
 
Rectal cancer 
Tofu 
Miso 
Tofu 
Miso 
≥ 3/wk 
 
177/354 
177/354 
153/306 
153/306 
0.79 (0.55-1.13) 
1.02 (0.67-1.53) 
0.69 (0.42-1.15) 
0.93 (0.54-1.60) 
Ji 1998 [107] 
 
China Population Gastric cancer Soy N/A 256/273 (Male) 
118/210 (Female) 
0.50 (0.40-0.70) 
0.80 (0.50-1.10) 
Gao 1999 [15] 
 
China Population Esophageal cancer 
Gastric cancer 
Soy ≥ 3/wk 
 
11/20 
8/20 
1.28 (0.26-6.31) 
0.20 (0.47-1.02) 
Huang 2004 [108] 
 
Japan Hospital Gastric 
 
CRC 
Soy 
Miso 
Soy 
Miso 
≥ 1/day 
≥ 3/wk 
≥ 1/day 
≥ 3/wk 
762/22198 
762/22198 
614/24125 
614/24125 
0.81 (0.70-0.95) 
0.98 (0.88-1.09) 
1.11 (0.92-1.33) 
0.89 (0.79-1.00) 
Ravasco 2005 [109] Portugal Population CRC Isoflavone ≥ 20 mg/day 70/70 0.30 (0.26-0.34) 
Cotterchio 2006 [110] Canada Populatioin CRC Isoflavone > 1.1 mg/day 300/607 0.71 (0.58-0.86) 
Ho 2006 [111] 
 
China Population CRC  Soy 
 
≥ 4/wk 114/153 (Male) 
103/154 (Female) 
0.66 (0.40-1.08) 
0.47 (0.28-0.81) 
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Rossi 2006 [112] Italy Hospital CRC 
Colon cancer 
Rectal cancer 
Isoflavone > 34 mg/day 245/245 
145/145 
359/359 
0.70 (0.56-0.87) 
0.81 (0.63-1.04) 
0.76 (0.63-0.91) 
Williams 2009 [113] 
 
USA Population Rectal cancer Soy 
 
N/A 162/222 
49/31 
0.91 (0.70-1.20) 
0.97 (0.52-1.81) 
Zhang 2009 [114] 
 
Korea Hospital Gastric  cancer Miso N/A 286/230 
175/229 
1.63 (1.24-2.14) 
0.57 (0.43-0.75) 
Ko 2010 [115] Korea Population Gastric cancer Isoflavone 
types: 
Genistein 
Daidzein 
Equol 
 
> 293 nmol/L 
> 291 nmol/L 
> 9 nmol/L 
131/393  
0.54 (0.31-0.93) 
0.21 (0.08-0.58) 
0.50 (0.27-0.90) 
Budhathoki 2011 [116] 
 
Japan Population 
 
CRC 
 
 
 
Rectal 
 
Soy 
 
Isoflavone 
 
Soy 
Isoflavone 
26.8 g/day 
 
74.4 mg/day 
66/85 (Male) 
79/78 (Female) 
63/85 (Male) 
73/78 (Female) 
68/68 (Male) 
 
0.65 (0.41-1.03) 
0.92 (0.50-1.67) 
0.68 (0.42-1.10) 
0.94 (0.52-1.71) 
0.56 (0.30-1.02) 
0.47 (0.25-0.86) 
 
 
Reference Location Group Type of Neoplasm Soy/isoflavone 
Intake 
Serving Sizes Total Cases Cohort size OR 
Cohort Studies         
Nomura 1990 [117] 
 
USA Population Gastric cancer Tofu 
Miso 
≥ 5/wk 
 
3/164 (Male) 
3/168 (Male) 
7990 
7990 
0.70 (0.20-2.30) 
0.90 (0.50-1.30) 
Kato 1992 [118] Japan Population Gastric cancer Miso ≥ 2/day 18 9735 1.04 (0.48-2.25) 
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Inoue 1996 [119] 
 
Japan Population Gastric cancer Miso Daily 
 
34/484  5373 362 (0.79-
16.70) 
Galanis 1998 [120] 
 
USA Population Gastric cancer Miso ≥ 1/wk 
 
33/1969 (Male) 
24 /2234 (Female) 
5610 
6297 
1.20 (0.70-2.00) 
1.30 (0.70-2.40) 
Nagata 2002 [121] 
 
Japan 
 
Population Gastric cancer Soy 
 
140 g/day 
127 g/day 
29 (Male) 
9 (Female) 
14427 
17125 
0.50 (0.26-0.93) 
0.53 (0.23-1.22) 
Ngoan 2002 [122] 
 
Japan Population Gastric cancer Tofu 
Miso 
≥ 1/day 
≥ 2/day 
19/1210 (Male) 
10/405 (Male) 
9/1531 (Female) 
2/372 (Female) 
1229 
415 
1540 
374 
0.90 (0.40-1.80) 
1.40 (0.70-3.20) 
0.80 (0.30-2.20) 
0.70 (0.20-3.40) 
Ito 2003 [123] 
 
Japan Population Gastric cancer Soy ≥ 3/wk 
≥ 1/day 
248 (Female) 
315 (Female) 
17515 
21784 
0.95 (0.79-1.14) 
1.05 (0.88-1.26) 
Khan 2004 [124] Japan Hospital Gastric cancer 
CRC 
 High 248/1734  0.48 (0.33-0.69) 
Iso 2005 [125] 
 
Japan Population Gastric cancer 
 
Colon cancer 
 
Rectal cancer 
Soy, Miso ³ 5/wk 
 
189 (Male) 
127 (Female) 
58 (Male) 
57 (Female) 
49 (Male) 
33 (Female) 
10764 
18071 
0.96 (0.79-1.17) 
1.34 (1.02-1.76) 
1.12 (0.78-1.62) 
0.87 (0.60-1.26) 
1.21 (0.81-1.83) 
1.00 (0.60-1.68) 
Sauvaget 2005 [126] 
 
Japan Population Rectal Cancer Tofu 
Miso 
≥ 5/wk 
 
182 
460 
38576 1.01 (0.85-1.20) 
1.01 (0.88-1.16) 
Tokui 2005 [127] 
 
Japan Population Gastric cancer Tofu 
 
Miso 
≥ 1/day 
 
124 (Male) 
93 (Female) 
415 (Male) 
201 (Female) 
110792 1.07 (0.73-1.58) 
1.41 (0.75-1.58) 
1.44 (0.86-2.42) 
1.46 (0.81-2.61) 
Oba 2007 [128] Japan Population Colon cancer Soy 141 g/day 46 (Male) 13894 1.24 (0.77-2.00) 
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Isoflavone 
128 g/day 
55 mg/day 
28 (Female) 
49 (Male) 
33 (Female) 
16327 0.56 (0.34-0.92) 
1.47 (0.90-2.40) 
0.73 (0.44-1.18) 
Akhter 2008 [129] 
 
Japan 
 
Population CRC 
 
Soy 
 
Miso 
 
Isoflavone 
≥ 3/wk 
 
127 (Male) 
103 (Female) 
131 (Male) 
100 (Female) 
131 (Male) 
106 (Female) 
68722 
71698 
 
0.89 (0.68-1.17) 
1.04 (0.76-1.42) 
0.88 (0.64-1.10) 
1.03 (0.75-1.43) 
0.89 (0.67-1.17) 
1.07 (0.78-1.47) 
Butler 2008 [130] 
 
Singapore Population CRC Soy 
Isoflavone 
254 g/day 
26 mg/day 
240 
240 
15090 0.95 (0.78-1.16) 
0.95 (0.79-1.13) 
Yang 2009 [131] China Population CRC Isoflavone 48.9 mg/day 108 (Female) 74942 0.76 (0.56-1.01) 
Hara 2012 [132] 
 
Japan Hospital Gastric cancer Soy 
 
Miso 
 
Isoflavone 
140 g/day 
 
449 mL/day 
 
48.5 mg/day 
229 (Male) 
81 (Female) 
282 (Male) 
82 (Female) 
259 (Male) 
91 (Female) 
39569  
 
45312 
1.02 (0.82-1.25) 
0.99 (0.71-1.38) 
1.17 (0.94-1.47) 
0.71 (0.50-1.01) 
1.00 (0.81-1.24) 
1.07 (0.77-1.50) 
Ko 2013 [133] 
 
Korea Population Gastric cancer Soy 
 
Miso 
 
≥ 1/day 
 
49 
15 
80 
35 
3598  
5960 
0.77 (0.52-1.13) 
0.41 (0.22-0.78) 
1.06 (0.93-1.21) 
1.10 (0.90-1.34) 
Kweon 2013 [134] 
 
China Population Gastric cancer Tofu 
 
(Soy milk, dry/ 
fresh bean, 
bean sprout, 
other) 
> 8.4 g/d 
> 6.8 g/d 
 
52 (Male) 
70 (Female) 
 
32184 0.64 (0,42-0.99) 
0.82 (0.57-1.17) 
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19 case-controls and 16 cohort studies provided data on soy intake. The combined OR was 
consistent with an inverse association between soy consumption and GI cancer, calculated 
to be 0.93 (95% CI: 0.87-0.99; p-value heterogeneity=0.01), showing only a slight decrease in 
risk. Results for both case-control (OR, 0.86; 95% CI: 0.72-1.02); p-value heterogeneity=0.07) 
and cohort studies (OR, 0.97; 95% CI: 0.90-1.03; p-value heterogeneity=0.21) were similar. 
Analysis of variables including country, gender, study design, type of soy consumed and 
cancer type, were conducted (Table 2.2).  Egger’s regression analysis for assessment of 
publication bias of the studies included in this meta-analysis found no significant bias 
(p<0.001) (Figure 2.1).  
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Table 2.2 Odd ratios with 95% CIs for variables examined for the association between soy 
intake and gastrointestinal neoplasm risk 
Factor OR (95% CI) 
Study Design  
Case control 0.86 (0.72-1.02)   
Cohort 0.97 (0.90-1.03)  
Population gender  
Male 0.93 (0.87-0.99)  
Female 0.92 (0.85-0.99)  
Neoplasm type  
Gastric cancer 0.94 (0.85-1.05)  
Colon cancer 0.92 (0.96-0.99)  
Rectal cancer 0.94 (0.80-1.09)  
CRC 0.92 (0.96-0.99)  
Preparation  
Non-fermented 1.03 (0.92-1.15)  
Fermented 0.97 (0.88-1.06)  
Soy type  
Tofu 1.05 (0.92-1.21)  
Miso 0.96 (0.87-1.06) 
Country  
 
China 0.81 (0.74-0.87) 
Japan 0.95 (0.92-0.99) 
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Korea 1.02 (0.93-1.11) 
USA 0.96 (0.82-1.13) 
Isoflavone  
Overall 0.73 (0.59-0.92) 
CRC 0.76 (0.59-0.98) 
Gastric 0.67 (0.45-1.02) 
Female 0.91 (0.77-1.08) 
Male 0.88 (0.71-1.09) 
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Figure 2.1 Funnel plot showing studies assessed for publication bias of soy intake and GI 
cancer risk 
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When analysing according to GI sites, colon cancer (OR, 0.92; 95% CI: 0.96-0.99; p-value 
heterogeneity= 0.163) and CRC (OR, 0.92; 95% CI: 0.87-0.97; p-value heterogeneity= 0.3) 
showed a weak but statistically significant reduction in risk. Gastric cancer and rectal cancer 
were associated with a small reduction in risk as well, however the results were not 
significant. Only 2 studies examined the effects of soy intake on esophageal cancer risk and 
hence were not included in the analysis. 
 
7 case-control and 12 cohort studies specifically examined gender variation on the influence 
of soy intake on GI cancer risk. Our analysis showed little difference between men and 
women. There is a modest but statistically significant inverse association for both men (OR, 
0.93; 95% CI: 0.87-0.99; p-value heterogeneity=0.01) and women (OR, 0.92; 95% CI: 0.85-
0.99; p-value heterogeneity=0.03). Subgroup site specific analysis showed that the 
association was statistically significant for colon cancer in women (OR, 0.85; 95% CI: 0.73-
0.99; p-value heterogeneity=0.4).  
 
Of the 41 included studies only 7 were from Western countries, the rest were of Asian 
origin. Studies from China and Japan showed a reduced risk in GI cancers with ORs of 0.81 
(95% CI: 0.74-0.87; p-value heterogeneity<0.001) and 0.95 (95% CI: 0.92-0.99; p-value 
heterogeneity= 0.03) respectively. 
 
Results for fermented and non-fermented soy products were similar, yielding ORs of 0.97 
(95% CI: 0.88-1.06; p-value heterogeneity= 49.13) and 1.03 (95% CI: 0.92-1.15; p-value 
heterogeneity= 0.104) respectively. Due to a large number of studies from Asian countries 
assessing tofu (bean curd) and miso (soybean paste soup) intake, we further conducted 
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stratified analysis to determine the effects of specific soy products. Our results showed no 
significant association or difference between intake of either soy product and GI cancer risk. 
5 case-control and 5 cohort studies included the subgroup analysis on dietary isoflavone 
intake (Figure 2.2).  
 
Figure 2.2 Forest plot of isoflavone intake and GI cancer risk   
 
 
 
Combined analysis yielded a statistically significant inverse association with a risk estimate 
of 0.73 (95% CI: 0.59-0.92; p-value heterogeneity=0). Site specific evaluation showed a 
significant inverse association with CRC (OR, 0.76; 95% CI:0.59-0.98; p-value 
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heterogeneity=0) only. Only 5 studies provided separate data on men and women, our 
analysis yielded very similar results for either gender. 
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2.4 Discussion  
Our results show that dietary isoflavone intake is strongly associated with a decrease in risk 
of developing GI cancers. Evidence for the consumption of soy and GI cancer intake has not 
been as consistent, showing only a small decrease in risk. To our knowledge, this is the first 
systematic review to investigate soy and dietary isoflavone intake in relation to GI cancer 
risk, taking into account the outcome of different anatomic subsites, and influence of 
gender differences and other covariants.  
 
All but one study included in our analysis of the effects isoflavone intake have been 
published within the past decade. Results from 7 out of the 10 studies support the 
hypothesis that isoflavone is inversely associated with GI cancer risk. Soybeans  and  soy  
products  contain roughly  1-3 mg  isoflavones  per  gram  protein. Isoflavones are also 
known as “phytoestrogens” because of the structural and metabolic similarities to 
mammalian estrogens [7]. They help to regulate estrogen levels in the body by acting on 
estrogen receptors in the body.  Epidemiological and clinical studies have shown a 
significant decrease in CRC risk amongst postmenopausal women who used hormone 
replacement therapies, providing evidence that colorectal cancer is hormone sensitive 
[135]. In human colorectal tumor cells, estrogen receptor gene expression was diminished 
or absent; introduction of an exogenous estrogen receptor gene in cultured colon 
carcinoma cells resulted in marked growth suppression [136]. These studies suggest that 
endogenous ovarian hormones and even phytoestrogens might modulate colorectal cancer 
risk. Isoflavones also have other chemoprotective properties. One small-scale intervention 
study showed that soy protein containing isoflavone reduces crypt cell proliferation in colon 
mucosa biopsies from male and female subjects with a history of colon polyps or colon 
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cancer [137]. Other anticancer activities included a decrease in abnormal cellular 
proliferation and the induction of apoptosis and inhibition angiogenesis [84, 86]. When 
examining site specific differences, currently there are no hypothesized mechanisms for soy 
contributing to the development of gastric or rectal cancer, but it could be postulated that 
mechanisms proposed for colon cancer are similar. 
 
Our analysis revealed only a very small decrease in GI cancer risk. This discrepancy may 
relate to several modifying factors, including the specific type of soy consumed, its 
preparation and gender differences. Wu et al. [9] recently did a thorough review and a 
meta-analysis of soy foods and the risk of stomach cancer. Pooled results from the meta-
analysis suggested that the risk of stomach cancer may depend on the method of 
preparation of the soy food. The findings indicated that the risk was lower in association 
with high intake of nonfermented soy foods (and higher with high consumption of 
fermented soy foods. Messina et al.’s review of in vitro and in vivo data on colon cancer 
provided similar suggestions [82]. Results from a recent meta-analysis on soy intake and CRC 
risk, which reviewed 15 case control and cohort studies, generally suggest an inverse 
association between higher soy consumption and colon cancer onset, however, nearly all of 
the confidence intervals overlap 1.0 [8]. Of the six case-control studies that evaluated the 
association between soy consumption and rectal cancer (732 cases), the point estimates 
generally suggest an inverse association with unfermented soy consumption and rectal 
cancer onset but not fermented soy products.  The same study also reported a 21% 
reduction in CRC risk in women. These findings were not seen in our stratified analyses.  
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Results from human trials and animal studies have also been conflicting. One human 
intervention trial providing either a soy or casein supplement for 12 months reported 
reductions in colon epithelial cell proliferation in the soy group [137]. Another showed that 
miso dose-dependently lowered the mean numbers of aberrant crypt foci, an early marker 
for tumorigenesis, in the colons of male rats [138]. On the other hand, of the three studies 
that specifically examined  the  effect of  soy  protein  isolate  on  chemically  induced  
colonic cancer,  none  found  a  reduction  in  the  rate  of carcinogenesis  [89-91].  
Furthermore, one study found  that  soy  protein  isolate  increased  colonic  cell  
proliferation [139].  
 
The ability of these studies to detect a true relationship depends on a number of aspects of 
the assessment of soy food consumption. Results may be influenced by inconsistent 
measurement tools for evaluating dietary intake, sensitivity of the questionnaire or 
interview to assess relevant food items for soy intake, and/or the soy content of food.  Few 
studies were originally designed to test the effect of soy as a risk factor or included portion 
sizes. Measurement standards differed across the studies, the categories of high 
consumption ranged from a low of one time or more per week to a high of three times or 
more per day. This inconsistency and the absence of standardized and comprehensive 
measurements undermine existing evidence.  To address this issue out study included a 
separate analysis using standardized measurements of consumption frequency across all 
relevant studies to provide a more unified body of evidence. 
 
Another limitation is that the studies included in our analysis varied in their measurement of 
soy content. This is partly due to the difference in composition of soy in the Asian and 
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Western diet. Asian studies, which comprise the majority of our data, generally measured 
intake of only one or two types of soy, such as miso or tofu, whereas the soy type was not 
specified in most studies from Western countries. This leads to potential misclassification 
and can complicate interpretation of the findings. Results from our stratified analysis did not 
show any significant difference between studies that examined soy as a whole food group 
versus specific soy types and method of preparation, suggesting that such modifying factors 
do not play a prominent role. However, on examining the differences between countries, 
the correlation of the protective effects of soy on GI cancer was stronger in countries such 
as China and Japan, as compared with USA. This may relate to higher levels of soy intake and 
a greater variety on the type of soy consumed. 
 
In addition, as with all questionnaire-based retrospective studies, reliability of results might 
suffer from measurement and reporting bias. The observed risk estimate for case-control 
studies was similar to that for cohort studies which suggests that in this instance recall bias 
does not have a prominent effect. Moreover, while most studies adjusted for age and 
gender in the calculation of risk estimates, not all parameters were considered. A meta-
analysis would not adequately adjust for this. 
 
In summary, the main findings of this study support an inverse association between 
isoflavone intake and GI cancer risk. Evidence for the chemoprotective effects of soy as a 
food group in general is much weaker, with only a small decrease in GI cancer risk. The 
correlation appears to be significant in CRC and amongst Asian populations. Further 
research should evaluate isoflavone content within different soy types when measuring 
exposure, paying attention to the patterns of consumption amongst different ethnic groups 
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and adjusting for cofounders. Measurements of consumption should be provided in 
quantifiable terms. 
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Chapter Three 
Eggs and Gastrointestinal Cancer risk 
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3.1 Introduction 
The association between risk of GI neoplasms and consumption of foods of animal origin has 
been investigated in many studies. Eggs provide roughly 1.2 per cent of available food 
energy worldwide, with consumption being highest in the Far East, North America, and 
Europe, contributing a significant portion of dietary cholesterol, protein, minerals, folate 
and B group vitamins [11]. Given that eggs are an important component of diet in the 
developed world, an evaluation of their specific role in GI neoplasm development is 
warranted.  
Epidemiological studies have yielded conflicting and controversial results, although a 
positive, insignificant relation was found in most studies. One systematic review reported a 
consistent positive association between egg intake and colorectal cancer (CRC) risk in nine 
out of eleven studies included, with odds ratios (OR) or relative risks (RR) ranging 1.1-8.2 for 
high versus low intake [12]. Some studies also suggested an increased risk of esophageal 
and gastric cancers [14-18]. Despite this, little is known about the potential relation 
between egg consumption and the risk of GI cancers. Currently no systematic review exists 
to thoroughly assess and unify the epidemiological evidence.  
The mechanisms which underlie the associations between eggs and GI cancer risk remain 
hypothetical. Previous studies have suggested that eggs could promote colorectal 
carcinogenesis due to their high cholesterol content [12]. Eggs are amongst the top 
contributors of cholesterol to the average Australian and US diet [140]. High intakes of 
cholesterol have been shown to increase the formation of secondary bile acids in humans 
and animals and promote the induction of colorectal tumors in animal models [141, 142].  
Egg yolk was also shown to increase the frequency of  gall-bladder  contraction  and  
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subsequent exposure  of  bile  acids  to  the  intestine [36]. There is strong evidence to 
suggest that bile acids are carcinogens in GI cancer [13]. Another cohort study reported a 
positive correlation between egg consumption and colorectal adenomas, precursors of CRC 
[143]. In addition, eggs are one of the few food sources that contain high concentrations of 
choline [144]. Animal studies showed that a choline enriched diet was associated with a 
higher incidence of  hepatocellular carcinoma [145]. Choline  kinase, an  enzyme  that  
breaks down choline, is also elevated in colon cancer[146].  
Although current understanding of the biological mechanisms involved is very limited, a 
multifactorial process is plausible and warrants further investigation, especially given the 
relatively strong evidence in risk reported with greater egg consumption in some 
epidemiological studies. Information on the amount consumed and the frequency of 
consumption would help to identify dose relationships and substantiate any association. 
Various epidemiological studies have used different parameters in reporting the serving 
sizes and hence descriptions of “high” and “low” intakes are highly varied, which 
undermines the collective evidence of the presence of an association. 
This systematic review aims to summarize epidemiological findings as well as provide a 
unified body of evidence of the serving portions of egg consumed and its effect on GI 
neoplasm development so as to form guidelines for egg consumption and guide future 
investigations. 
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3.2 Methods 
Study Protocol 
Literature searches of epidemiological studies in this systematic review were performed 
using the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines 
where possible [28]. The following electronic databases were searched: Medline, PubMed, 
ISI Web of Science, Current Contents Connect and Embase. The search included all 
observational studies published up to May 25, 2013. Key terms including ‘Diet’ AND ‘GI 
neoplasm’ were searched as text words and as exploded medical subject headings where 
possible. Titles and abstracts were then screened for relevant data on egg intake and GI 
neoplasm risk. References in the relevant review articles from the bibliographic database 
search were also checked for appropriate studies. No language restrictions were used in 
either the search or study selection.  A search for unpublished literature was not performed.  
Study Selection 
The following inclusion criteria was applied in the screening of articles: (1) original data on 
egg consumption and GI neoplasms risk, that of the esophagus, stomach and/or colorectum, 
was provided, (2) the risk point estimate was reported as OR or RR, or the data was 
presented such that an OR could be calculated; (4) the 95% confidence interval (CI) was 
reported, or the data was presented such that the CI could be calculated. 
Data Extraction 
Data was performed via a standardized data extraction form, collecting information on the 
publication year, study design, number of cases and controls, total sample size, temporal 
direction, population type, country, ethnicity of sample group, case control matching, 
neoplasm type, number of adjusted variables, the risk estimates or data used to calculate 
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the risk estimates, CIs. Quality of the studies was not assessed and authors were not 
contacted for missing data. Adjusted odds ratios were extracted in preference to non-
adjusted odds ratios, however, where odds ratios were not provided, unadjusted ORs and 
CIs were calculated. Where more than one adjusted ratio was reported, the ratio with the 
highest number of adjusted variables was chosen. Where multiple risk estimates were 
available in the same study, for example due to the use of different comparator groups, 
they were included as separate risk estimates.  
Statistical Analysis 
Pooled odds ratios and 95% confidence intervals were calculated for the effect of egg 
consumption on the risk of GI neoplasms using a random effects model, model of 
DerSimmonian and Laird [29]. Heterogeneity with Cochran’s Q statistic was tested, with 
P<0.10 indicating heterogeneity, and the degree of heterogeneity was quantified using the 
I
2
 statistic, which represents the percentage of the total variability across studies due to 
heterogeneity. I
2 values of 25, 50 and 75% corresponded to low, moderate and high degrees 
of heterogeneity respectively [30]. Publication bias was quantified using the Egger’s 
regression model. All analyses were performed with comprehensive Meta-analysis [31]. 
As different methods were used to report egg intake, subgroup analysis on serving sizes 
involved categorizing studies using a standardized measurement of consumption per week, 
based on an average weight of 55 grams per egg. Two different classification methods were 
developed: (1) Less than 3, or 3 or more eggs per week; (2) Less than 3, 3 to 5, or more than 
5 eggs per week. The second method did not include studies which only reported 
consumption frequency.   
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Analyses were performed to determine whether data collection design influenced the 
pooled estimate. Several parameters were evaluated: (1) interviews versus self-
administered questionnaires; (2) the use of validated food frequency questionnaires versus 
non-validated ones; (3) the inclusion of a pilot study versus without. An additional sensitivity 
analysis was done by excluding studies that measure dietary habits more than 1 year before 
diagnosis. 
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3.3 Results 
The literature searches identified 538 articles for evaluation. Title and abstract screening 
excluded 475 articles due to duplicates, non-human or non-original research. Full text 
screening excluded 19 articles- 13 studies did not include eggs in the dietary assessment, 
confidence intervals could not be calculated in 3 studies, 2 studies did not present original 
data, and the risk estimate was not provided in 1 study. 37 case-control and 7 cohort studies 
were eligible for inclusion, which contained a total of 424867 participants and 18852 GI 
neoplasm cases, Characteristics of included studies are outlined in Table 3.1. Exclusion 
reasons for the remainder included: original epidemiological data on the association 
between egg intake and GI neoplasm risk was not provided; risk estimates could not be 
obtained; CIs were not provided and could not be calculated. 
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Table 3.1 Characteristics of included studies reporting odd ratios and 95% CIs for the association between egg intake and GI neoplasm risk 
Reference Location Ethnic Group Group Type of Neoplasm Total Cases/ 
Controls or Cohort 
size 
Serving Sizes OR 
Case-Control Studies           
Risch 1985 [147] Canada Caucasian Hospital Gastric cancer 246/246 100g/day 2.86 (1.09-7.51) 
Macquart-Moulin 1987 
[148] 
Marseilles Caucasian Hospital Colorectal polyps 252/238 >30g/day 1.09 (0.64-1.88) 
Yu 1988 [149] USA Multiethnic Population Gastric cancer 128/128 >5 eggs/week 1.20 (0.60-2.30) 
Benito 1990 [150] Spain Caucasian Hospital CRC 286/295 >2.5 times/week 2.78 (1.36-5.67) 
Gonzalez 1991 [14] Spain Caucasian Population Gastric cancer 354/354 >44g/day 1.60 (0.90-2.70) 
Hu 1991 [99] China Asian Hospital Rectal cancer 116/116 (Male) High 3.07 (1.22-7.72) 
Hoshiyama 1992 [100] Japan Asian Hospital Gastric cancer 294/202 >5 times/week 0.90 (0.50-1.70) 
Iscovich 1992 [151] Argentina Caucasian Population Colon cancer 110/220 >87 times/year 4.66 (1.51-14.38) 
Steinmetz 1993 [37] Australia Caucasian Hospital Colon cancer 90/180 (Male) 
75/147 (Female) 
>7 eggs/week 1.29 (0.69-2.41) 
2.69 (1.16-6.22) 
Centonze 1994 [152] Italy Caucasian Population CRC 119/115 >12g/day 0.46 (0.18-1.21) 
Cornée 1995 [153] France Caucasian Hospital Gastric cancer 92/128 >29g/day 0.84 (0.42-1.68) 
Inoue 1995 [103] Japan Asian Hospital Proximal colon cancer 
Distal colon cancer 
Rectal cancer 
Proximal colon cancer 
Distal colon cancer 
Rectal cancer 
256/5500 (Male) 
 
 
173/16421 (Female) 
>3 times/week 2.00 (1.00-4.00) 
1.20 (0.70-1.90) 
1.00 (0.70-1.40) 
1.00 (0.50-1.90) 
1.00 (0.60-1.70) 
0.80 (0.50-1.40) 
Kampman 1995 [154] Netherlands Caucasian Hospital Colon cancer 232/259 >19g/day 1.17 (0.68-2.01) 
Shannon 1996 [155] USA Caucasian Population Colon cancer 196/180 (Male) 
149/144 (Female) 
>3 eggs/week 1.10 (0.65-1.85) 
1.05 (0.59-1.86) 
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Franceschi 1997 [156] Italy Caucasian Population CRC 1953/4154 >2 eggs/week 0.92 (0.75-1.14) 
Marchand 1997 [157] USA Multiethnic Hospital CRC 698/698 (Male) 
494/494 (Female) 
>29g/day 
>19g/day 
2.70 (1.70-4.00) 
2.30 (1.40-3.70) 
Brown 1998 [158] USA African 
American, 
Caucasian 
Population Esophageal cancer 114/681 (Caucasian 
Male) 
219/557 (Africa 
American Male) 
High 2.50 (1.40-4.60) 
 
1.40 (0.60-2.90) 
Ji 1998 [107] China Asian Population Gastric cancer 770/819 (Male) 
354/632 (Female) 
>17.5 
eggs/month 
0.60 (0.40-0.80) 
0.50 (0.40-0.80) 
Launoy 1998 [159] France Caucasian Hospital Esophageal cancer 208/399 (Male) >45g/day 1.17 (0.68-2.08) 
Boutron-Ruault 1999 
[160] 
France Caucasian Hospital CRC 171/309 40.5g/day 1.10 (0.60-2.10) 
Gao 1999 [15] China Asian Population Esophageal cancer 
Gastric cancer 
234/234 >3 times/week 3.35 (1.54-7.30) 
3.79 (2.20-7.10) 
Levi 1999 [17] Switzerland Caucasian Hospital CRC 223/491 >2.5 eggs/week 1.30 (0.84-2.02) 
Bosetti 2000 [18] Italy Caucasian Hospital Esophageal cancer 304/743 >2.9 eggs/week 1.86 (1.00-3.43) 
Mathew 2000 [161] India Asian Hospital Gastric cancer 305/194 Daily 1.70 (0.70-4.30) 
Slattery 2000 [162] USA Multiethnic Population Colon cancer 1624/1963 >3 eggs/week 1.30 (1.00-1.80) 
Munoz 2001[163] Venezuela Caucasian Hospital Gastric cancer 302/485 High 0.83 (0.52-1.34) 
Nishimoto 2002 [16] Brazil Hispanic Population Gastric cancer 236/236 Daily 3.20 (1.70-6.00) 
Senesse 2002 [164] France Caucasian Population Small colorectal 
adenoma 
Large colorectal 
adenoma 
362/427 >45g/day 1.40 (0.80-2.60) 
1.00 (0.60-1.70) 
Dray 2003[165] France Caucasian Population CRC 148** (no # controls 
given) 
High 1.10 (0.52-2.33) 
Stefani 2004 [166] Uruguay Caucasian Hospital Gastric cancer 248/1734 High 0.48 (0.33-0.69) 
Hu 2007 [54] Canada Caucasian Population Proximal Colon cancer 375/1588 (Male) >4 eggs/week 1.40 (0.70-2.50) 
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345/1441 (Female) 1.30 (0.60-2.90) 
Hu 2007 [53] Canada Caucasian Population Rectal Cancer 814/1588 (Male) 
540/1441 (Female) 
>4 eggs/week 1.30 (1.00-1.70) 
0.90 (0.50-1.60) 
Lucenteforte 2008 [167] Italy Caucasian Population Gastric cancer 230/547 >6 eggs/week 1.15 (0.77-1.70) 
Aune 2009 [168] Uruguay Caucasian Hospital Esophageal cancer 
Gastric cancer 
Colon cancer 
Rectal cancer 
870/2032 >3.5 eggs/week 1.69 (0.98-2.93) 
1.19 (0.69-2.04) 
3.21 (1.68-6.11) 
0.90 (0.48-1.72) 
Ramadas 2009 [57] Malaysia Asian Population Colorectal adenoma 59/59 >3 times/week 0.55 (0.23-1.34) 
Williams 2009 [113] USA Caucasian, 
African 
American 
Hospital Rectal cancer 720/800 (Caucasian) 
225/159 (African 
American) 
4.2 eggs/week 
6.6 eggs/week 
1.07 (0.76-1.50) 
1.53 (0.73-3.20) 
Icli 2011 [169] Turkey Caucasian Population Gastric cancer 253/253 >3 times/week 1.20 (0.70-2.10) 
 
Cohort studies 
Guo 1994 [170] China Asian Population Esophageal cancer 
Gastric cancer 
659/29584 >5 times/month 0.80 (0.60-1.10) 
0.90 (0.70-1.20) 
Ngoan 2002 [122] Japan Asian Population Gastric cancer 50/13250  >1 egg/day 0.80 (0.40-1.60) 
Ito 2003 [123] Japan Asian Population Gastric cancer 341/24886 (Female) >3 times/week 1.16 (0.96-1.40) 
Kojima 2004 [171] Japan Asian Hospital Colon cancer 
Rectal cancer 
Colon cancer 
Rectal cancer 
180/45181 (Male) 
 
130/62643 (Female) 
Daily 1.54 (0.99-2.42) 
0.82 (0.54-1.26) 
1.17 (0.79-1.75) 
0.75 (0.39-1.46) 
Tokui 2005 [127] Japan Asian Population Gastric cancer 497/45181 (Male) 
252/62643 (Female) 
>1 egg/day 1.13 (0.79-1.62) 
2.32 (1.22-4.42) 
Fan 2008 [172] China Asian Population Esophageal cancer 68/18244 (Male) High 0.83 (0.51-1.35) 
Lee 2009 [173] China Asian Population CRC 109/73224 (Female) >44g/day 1.40 (1.10-2.0) 
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The combined OR was consistent with a positive association between egg consumption and 
GI neoplasm, calculated to be 1.15 (95% CI: 1.09-1.22; p-value heterogeneity <0.001), 
showing only a slight increase in risk. Analysis of  variables including country, gender, 
ethnicity, study population, study design, and neoplasm type, were conducted (Table 3.2).  
Egger’s regression analysis for assessment of publication bias of the studies included in this 
meta-analysis found significant bias (p<0.001). 
 
Figure 3.1 Funnel plot showing studies assessed for publication bias of egg intake and GI 
cancer risk 
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Table 3.2 Odd ratios with 95% CIs for variables examined for the association between egg 
intake and gastrointestinal neoplasm risk 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Factor OR (95% CI) 
Ethnicity  
Asian 1.07 (0.96-1.18)  
Caucasian 1.16 (1.09-1.24)  
African-American 1.40 (0.85-2.31)  
Study Design  
Cohort 1.02 (0.91-1.14)   
Case Control 1.19 (1.12-1.28)  
Population type  
Population 1.12 (1.05-1.20)  
Hospital 1.24 (1.11-1.39)  
Population gender  
Male 1.08 (0.94-1.23)  
Female 1.12 (0.98-1.28)  
Neoplasm type  
Esophageal cancer 1.25 (0.98-1.61)  
Gastric cancer 1.07 (0.96-1.20)  
Proximal colon cancer 1.31 (1.05-1.62)  
Distal colon cancer 1.11 (0.79-1.56)  
Colon cancer 1.29 (1.14-1.46)  
Rectal cancer 1.02 (0.89-1.15)  
CRC 1.32 (1.13-1.53)  
Colorectal adenoma 1.23 (1.01-1.51)  
Country  
USA 1.25 (1.05-1.49)  
Australia 1.46 (1.11-1.94)  
Canada 1.21 (1.06-1.38)  
China 1.04 (0.87-1.24)  
India 1.68 (1.01- 2.82) 
Japan 1.10 (0.99-1.22)  
France 1.16 (0.99-1.36)  
Netherlands 1.07 (0.79-1.47)  
Switzerland 1.07 (0.72-1.58)  
Turkey 1.11 (0.74-1.65)  
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In our dose response analysis, 38 studies reported either the serving sizes of eggs consumed 
or the frequency of consumption, 29 of which specified the amount of intake in quantifiable 
units. Stratification using the classification Method 1 identified 22 articles which reported a 
serving size of less than 3 eggs per week, and 30 articles which reported 3 or more eggs per 
week. Amongst these, 30 were case control studies and 5 were cohort studies, representing 
a total of 923 esophageal cases, 4009 gastric cancer cases, 2878 colon cancer cases, 2215 
rectal cancer cases, 2225 CRC cases, and 498 colorectal adenoma cases. Stratification using 
the classification Method 2 identified 17 studies which reported a serving size of less than 3 
eggs per week, 13 studies reported 3 to 5 eggs per week, and 18 studies reported more than 
5 eggs per week. 25 were case control studies, 2 were cohort studies. Among these, there 
were 1051 esophageal cancer cases, 2378 gastric cancer cases, 2385 colon cancer cases, 
1954 rectal cancer cases, 1995 CRC cases, and 464 colorectal adenomas. 
 
Both methods revealed a statistically significant dose-response relationship with egg intake 
and GI neoplasm risk (Table 3). With method I, the OR for an intake of less than 3 and 3 or 
more eggs per week were 1.14 (95% CI: 1.07-1.22; p-value heterogeneity =0.38) and 1.25 
(95% CI: 1.14-1.38; p-value heterogeneity =0.25) respectively. With method II, the OR for an 
intake of less than 3, 3 to 5, and greater than 5 eggs per week were 1.13 (95% CI: 1.06-1.21; 
p-value heterogeneity =0.25), 1.14 (95% CI: 1.01-1.29; p-value heterogeneity =0.06) and 
1.19 (95% CI: 1.01-1.39; p-value heterogeneity <0.001) respectively.  
 
Subgroup site specific analysis produced similar results using both classification methods, 
egg consumption posed a slight increase in risk of developing cancers of the stomach, colon 
and colorectum; higher amounts posed a greater risk, indicating a possible but small dose 
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effect. For the first classification method, the associations of egg intake and both colon 
cancer and CRC risk were statistically significant. With an intake of less than 3 eggs per 
week, the combined OR for colon cancer and CRC were 1.16 (95% CI: 1.02-1.32; p-value 
heterogeneity =0.6) and 1.19 (95% CI: 1.04-1.36; p-value heterogeneity =0.18) respectively. 
With an intake of 3 or more eggs per week the combined OR for colon cancer and CRC were 
1.28 (95% CI: 1.09-1.51; p-value heterogeneity =0.14) and 1.71 (95% CI: 1.26-2.32; p-value 
heterogeneity =0.08) respectively. For the second method, the association was statistically 
significant for colon cancer only. The OR for an intake of less than 3, 3 to 5, and greater than 
5 eggs per week were 1.16 (95% CI: 1.02-1.32; p-value heterogeneity =0.62), 1.15 (95% CI: 
0.95-1.41; p-value heterogeneity =0.47) and 1.42 (95% CI: 1.08-1.87; p-value heterogeneity 
=0.34) respectively.  
 
With the first classification method, a borderline increased risk of GI cancers was found in 
Caucasians, with an observed dose effect; the OR for less than 3 eggs consumed per week is 
1.17 (95% CI: 1.1-1.25; p-value heterogeneity =0.49), and 1.26 for 3 or more eggs per week 
(95% CI: 1.16-1.38; p-value heterogeneity =0.3).  
With the second method, Caucasians were also shown to have a slight increase in risk of GI 
cancers with egg consumption, however, there is no observable dose effect; the OR for 
serving sizes of less than 3, 3 to 5, and greater than 5 eggs per week are 1.14 (95% CI: 1.07-
1.21; p-value heterogeneity =0.5), 1.18 (95% CI: 1.04-1.34; p-value heterogeneity =0.41), 
and 1.29 (95% CI: 1.07-1.55; p-value heterogeneity =0.47) respectively. 
 
When examining the effect of egg consumption without taking into account the serving 
sizes, there is a small but statistically significant positive association between egg 
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consumption and CRC (OR, 1.32; 95% CI: 1.13-1.53; p-value heterogeneity <0.001), colon 
cancer (OR, 1.29; 95% CI: 1.14-1.46; p-value heterogeneity =0.22) and proximal colon cancer 
(OR, 1.31; 95% CI: 1.05-1.62; p-value heterogeneity =0.86) (Table 3.3). 
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Table 3.3 Odd ratios with 95% CIs for variables examined for the association between egg intake and GI neoplasm stratified by serving sizes 
using 2 classification methods, method 2 did not include studies which only reported consumption frequency.   
  Method 1 Method 2 
Serving sizes (eggs/week) <3 3 <3 3 - 5 >5 
GI 
divisions 
Esophageal 1.19 (0.89-1.60) 1.32 (0.83-2.09) 1.28 (0.98-
1.68) 
    
Gastric 1.11 (0.92-1.32) 1.19 (1.02-1.40) 0.99 (0.80-
1.24) 
1.05 (0.89-1.24) 1.26 (0.88-1.79) 
Colon 1.16 (1.02-1.32) 1.28 (1.09-1.51) 1.16 (1.02-
1.32) 
1.15 (0.95-1.41) 1.42 (1.08-1.87) 
Rectal 1.06 (0.90-1.26) 0.91 (0.78-1.07) 1.06 (0.90-
1.26) 
1.09 (0.80-1.48) 0.90 (0.68-1.20) 
CRC 1.19 (1.04-1.36) 1.71 (1.26-2.32) 1.15 (1.04-
1.26) 
  1.32 (0.97-1.80) 
Gender Male 1.11 (0.99-1.24) 1.02 (0.92-1.12) 1.11 (0.99- 0.89 (0.76-1.05) 0.94 (0.81-1.10) 
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1.24) 
Female 1.14 (0.95-1.38) 1.06 (0.95-1.18) 1.14 (0.95-
1.38) 
1.12 (0.96-1.31) 1.12 (0.93-1.35) 
Ethnicity African American 0.78 (0.38-1.60) 1.33 (0.80-2.21) 0.78 (0.38-
1.60) 
1.18 (0.59-2.36) 1.53 (0.73-3.20) 
Asian 0.99 (0.89-1.10) 1.00 (0.93-1.09) 0.94 (0.79-
1.11) 
1.00 (0.89-1.13) 0.97 (0.85-1.10) 
Caucasian 1.17 (1.10-1.25) 1.26 (1.16-1.38) 1.14 (1.07-
1.21) 
1.18 (1.04-1.34) 1.29 (1.07-1.55) 
Multiethnic 1.11 (0.87-1.41) 1.60 (1.23-2.09) 1.11 (0.87-
1.41) 
1.00 (0.66-1.52) 1.20 (0.62- 2.35) 
Overall 1.14 (1.07-1.22) 1.25 (1.14-1.38) 1.13 (1.06-
1.21) 
1.14 (1.01-1.29) 1.19 (1.01-1.39) 
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Western countries including USA (OR, 1.25; 95% CI: 1.05-1.49; p-value heterogeneity 
<0.001), Australia (OR, 1.46; 95% CI: 1.11-1.94; p-value heterogeneity =0.71) and Canada 
(OR, 1.21; 95% CI: 1.06-1.38; p-value heterogeneity =0.36) exhibit increased risk in GI 
cancers with egg consumption (Table 3.2). 
 
33 case-control studies collected data using trained interviewers (OR, 1.16; 95% CI: 1.08-
1.24; p-value heterogeneity <0.001) and 4 studies used self-administered questionnaires 
(OR, 1.21, 95% CI: 1.10-1.33; p-value heterogeneity =0.47). 5 studies included a pilot study 
in their methods (OR, 1.18; 95% CI: 1.03-1.37; p-value heterogeneity =0.36) while 32 did not 
(OR, 1.16; 95% CI: 1.09-1.24; p-value heterogeneity <0.001). 20 studies used validated food 
frequency questionnaires (OR, 1.17; 95% CI: 1.09-1.27; p-value heterogeneity <0.001), 17 
used questionnaires without stating the validity or reproducibility (OR, 1.15; 95% CI: 1.04-
1.28; p-value heterogeneity <0.001). The sensitivity analysis showed that studies which 
asked about dietary habits within a year before diagnosis had a pooled OR of 1.26 (95% CI: 
1.17-1.37; p-value heterogeneity <0.001), those that measured dietary patterns a year or 
more before had an estimate of 1.21 (95% CI: 1.14-1.28; p-value heterogeneity <0.001).  
 
 
 
 
 
 
 
 
  
77 
 
3.4 Discussion  
Our results show that egg consumption is associated with a very modest increase in the risk 
of developing neoplasms of the esophagus, stomach, colon, and colorectum. This 
correlation was stronger for Western populations. After stratification according to serving 
sizes, a significant and positive association persisted for colon cancer, with a small dose 
effect being observed. 
 
Different methods of quantifying the amount of eggs consumed have been used in dietary 
assessments. One study categorized a serving size of greater than 19 grams per day as high 
[154], while a similar serving size was classified as low in another study [14]. Steinmetz’s 
study, the only systematic review on this topic to date, included 15 case control and cohort 
studies in his analysis, in which he reported over 70% of studies of CRC showed increased 
risk with high egg consumption [12]. However, some of these studies reported different 
values as high consumption levels. This inconsistency is found in a large number of studies 
and as such undermines existing evidence. This paper attempts to address this issue by 
standardizing the measurement of serving sizes across all relevant studies to provide a more 
unified body of evidence. Two different measurement standards were used in the meta-
analysis and compared to reduce error from selection bias. The second method did not 
include studies which only listed frequency as a measure of egg intake as the absolute 
amount could not be quantified. Analysis showed that both methods produced similar 
findings.  
 
When examining site specific differences, currently there are no hypothesized mechanisms 
for eggs contributing to the development of esophageal or gastric cancer, but it could be 
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postulated that mechanisms proposed for colon cancer could be similar. A statistically 
significant dose related association was found only for colon cancer when both methods 
serving size stratification were considered. Reasons underpinning such an association 
remain poorly understood. An experimental study was conducted to examine egg intake 
and markers of crypt cell proliferation in the colon and rectum of patients with either 
disease free mucosa or adenomatous polyps [174]. High frequency of cell division within the 
crypt and displacement of proliferative zone towards the bowel lumen are biomarkers for 
increased risk of neoplasia. Results showed no indication of a causal association. A 
systematic review also showed that egg consumption did not have a substantial effect on 
the development of colorectal polyps [175]. It was suggested that egg consumption might 
be involved in the promotional, but not in the initiating phase of colorectal carcinogenesis.  
 
One of the main mechanisms that has been proposed is based on the high cholesterol 
content found in eggs. Animal studies have reported that animals fed a high-cholesterol diet 
displayed a high rate of chemically induced tumors [176]. However, there has been a lack of 
consistent evidence to support the notion that regular or near-regular egg ingestion leads to 
substantial elevation in serum lipids and total cholesterol levels. One study found that 
participants eating less than one egg per week had serum cholesterol levels greater than 
participants eating more than four eggs per week [177]. Therefore biological processes 
involving pathways other than direct effects on serum cholesterol levels may be considered. 
The metabolites of cholesterol such as cholesterol oxide, are formed via bacterial oxidation 
in bowel and may act to promote colon carcinogenesis [178]. Furthermore, higher intake of 
cholesterol has been shown to increase the formation of secondary bile acids in both 
humans and animals [141]. Dietary fat-dependent increases in secondary bile acids were 
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found to damage colonic lumen epithelial cells, consequently promoting the proliferation of 
the colorectal epithelium and tumor formation [179].  
 
Other more speculative carcinogenic mechanisms for eggs might also be considered. Egg 
yolk in the duodenum leads to a potent stimulation of cholecystokinin secretion which 
induces gall-bladder contraction [180]. Increased frequency of gall-bladder contraction 
could presumably lead to increased frequency of colonic exposure to potentially 
carcinogenic bile acids [13]. Eggs may also contribute to the dietary intake of heterocyclic 
amines which are formed when proteins are cooked at high temperatures [181]. 
Heterocyclic amines have been associated with the development of esophageal, gastric and 
colon cancers [182]. However, results from two case control studies indicate that this 
mechanism is unlikely; no difference in risk was observed for eggs cooked at a high 
temperature (fried or scrambled)  compared  with  eggs  cooked  at  a lower temperature 
(boiled or poached) [157, 168]. Further, egg is a rich source of dietary choline. One cohort 
study found an elevated risk of colorectal adenoma with increasing choline intake [143]. 
Once a tumor is initiated, growth into a detectable adenoma depends in part on choline 
availability because choline is needed in membrane production in all rapidly growing cells.  
The same study reported a statistically significant positive association with egg intake. Rats  
fed  a  choline-deﬁcient  diet  for  3  or  6  months followed  by  a  choline-supplemented  
diet  had  higher  incidence of  hepatocellular  carcinoma  than animals fed continuously a 
diet deﬁcient in choline [145].  Choline  kinase,  an  enzyme  that  converts choline to 
phosphocholine, an intermediate in the generation of membrane phospholipids, is elevated 
in human cancers, including colon cancer [146]. While there is limited evidence to provide a 
biological explanation of the possible dose-related association between eggs and GI cancer, 
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the process is likely to be multifactorial, and it can be speculated that increasing 
consumption of increases exposure to potential cancer-causing agents. 
 
Several limitations should be taken into account when interpreting the findings from the 
current study. Most methods involving  diet  recall  often  lack  validation  against some  
objective  reference  method  which again may lead to measurement and reporting bias. 
The studies included in our analysis largely differ in their dietary assessment of egg intake, 
with some studies reporting exposure in descriptive terms “high vs low” rather than in 
absolute quantities, and as such serve as a potential source of measurement error. Whilst 
this issue was addressed by standardizing the measurement of exposure across the studies 
in our analysis, inherent observational bias would not be eliminated. However, an 
evaluation of different data collection designs of the case-control studies included showed 
little differences in the risk estimates, suggesting that such bias did not play a prominent 
role. 
.  
Differences between cases and controls in their ability to recall past dietary habits is of 
concern in case-control studies. An evaluation of this issue in population samples has shown 
that such differences in recall are minor when cases are interviewed soon after diagnosis. 
Most studies in this paper were conducted within 3 months of diagnosis, and thus were able 
to keep recall bias between cases and controls to as low a level as possible. Measurement 
error may be greater in studies where patients were asked to recall their dietary intake 
several years before their diagnosis compared with studies that asked patients the same 
information from a more recent period (<1 year). Results from the sensitivity analysis 
showed little difference between the two.  Moreover, bias in the recall of egg intake by 
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cases should be limited given the limited knowledge and attention paid in the population to 
speciﬁc relations between eggs and GI cancer.  
 
In addition, while most studies adjusted for age and gender in the calculation of risk 
estimates, not all parameters were considered. Intake of diets high in eggs may be 
associated with other behaviors including physical inactivity, overweight and obesity, high 
intake of red and processed meats.  A meta-analysis would not adequately adjust for this. 
This may also serve as possible explanation for the positive correlation found between egg 
consumption and GI neoplasm amongst the Western population in which such factors are 
more prominent. The method preparation of eggs may be another confounding factor, but 
in the several studies that adjusted for this factor found that the association with eggs 
appears independent from the method of preparation since increased ORs were found for 
fried or scrambled eggs, as well as for boiled eggs.  
Recommendations for further epidemiological research on the relation of diet and GI 
neoplasms should include measurements of egg exposure in absolute quantifiable terms 
with details on the methods of preparation of eggs consumed when possible. A number of 
previous studies included eggs in their dietary assessment, but have not reported the risk 
estimates due to either lack of interest in reporting null findings or lack of interest in eggs as 
an aetiological hypothesis, investigators are encouraged to report relevant results in an 
effort to arrive at a more definitive conclusion. 
In summary, this systematic review provides evidence that egg consumption is associated 
with the risk of GI neoplasm development, more strongly correlated with Western 
populations. A statistically significant dose effect is observed in cancers of the colon in 
particular. The associations observed however appear weak, with only small differences 
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between high versus low levels of consumption, thus the hypothesis that egg consumption 
is involved in the development of GI neoplasms remains at best tenuous.  
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4. Summary 
Previous studies on diet and cancer prevention provide evidence of an association between 
GI cancer risk and certain food groups. However, each food group consists of a myriad of 
individual food types with varying nutritional components, making accurate establishment 
of a causal relationship difficult. The aim of this study is to evaluate the effects of three 
commonly consumed specific food types, (1) cruciferous vegetables, (2) soy and (3) eggs, 
towards GI cancer development, the goal of which is to provide further dietary 
recommendations and identify nutritional factors that show potential for future research. 
 
This study revealed that the intake of cruciferous vegetable is inversely associated with 
colon cancer risk. The consumption of broccoli in particular is demonstrated to be positively 
correlated with protection against CRC development. There is a positive correlation 
between GST genetic polymorphism and the capacity of cruciferous vegetables to exhibit 
chemoprotective properties, in which the GSTT1 null genotype confers a reduction 
colorectal neoplasm development risk.  
 
Egg consumption is associated with a very modest increase in the risk of developing 
neoplasms of the esophagus, stomach, colon, and colorectum. This correlation was stronger 
for Western populations. After stratification according to serving sizes, a significant and 
positive association persisted for colon cancer, with a small dose effect being observed. A 
statistically significant dose effect is observed in cancers of the colon in particular. The 
associations observed however appear weak, with only small differences between high 
versus low levels of consumption 
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Evidence for the consumption of soy in general and GI cancer intake shows only a small 
decrease in risk. The correlation appears to be significant in CRC and amongst Asian 
populations. There was negligible difference in response between men and women. Results 
for fermented and non-fermented soy products on GI cancer risk were also similar. Dietary 
isoflavone intake on the other hand is strongly associated with a decrease in risk of 
developing GI cancers, subsite analysis revealed an inverse association with CRC.  
 
A number of limitations underlie this study. FFQs employed in epidemiological studies 
provide only moderately accurate estimates of food intake.  A limited range of food items is 
measured, potentially omitting some sources of the food group under investigation. 
Selection bias and recall bias could have led to differential reporting. Investigations on 
nutritional constituents, for example, ITC in cruciferous vegetables and isoflavone in soy, 
rely on quantifying phytochemical exposure to constituents based on the weight or servings 
of the food type consumed and the resulting misclassification tends to attenuate the size of 
any true associations of nutrient intake with disease risk. On the other hand, if small 
observed associations are due to a real protective or harmful effect, then the true effect 
may be substantially larger and thus of greater public health importance. 
 
The methodology behind completing the meta-analysis had its own strengths and 
limitations.Limitations included the potential for publication bias, with null studies less likely 
to be published and therefore, potentially missing from the meta-analysis. This limitation 
can be minimized by assessing the distribution of studies around the effect line. 
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Another limitation is the lack of adequate adjustment for confounders. While most studies 
adjusted for age and gender in the calculation of risk estimates, not all parameters were 
considered. Intake of diets high in eggs may be associated with other behaviors including 
physical inactivity, BMI, total energy intake, or other genetic polymorphisms.  A meta-
analysis would not sufficiently adjust for this. Subgroup and sensitivity analysis allow for 
clarification of the impact of certain confounders.  
 
In addition, only one reviewer was used to assess studies against the inclusion criteria, 
opening the study up to potential bias in the studies included or excluded. This was 
minimized, however, through the application of clear and strict inclusion criteria such that 
the process to include and eliminate studies was as objective as possible.  
 
The strengths of this study lies in its quantitative analyses and systematic reviews of three 
individual food types, of which the soy and eggs are novel topics that have not yet been 
reviewed in past literature. Pooled results of meta-analyses allow for clarification of any 
potential associations through a uniform body of evidence. The new data contributes to the 
understanding of the role of diet and GI cancer prevention by offering insight into the 
effects of commonly consumed food subgroups under the umbrella of broad food 
categories.  
 
This study has identified a number of areas requiring further investigation as well as a 
number of areas offering promise for the future. 
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Each food group examined in this study has its own constellation of nutrients that may be 
associated with GI cancer risk. Certain components have been implicated with a stronger 
association, particularly with glucosinolates in cruciferous vegetables and isoflavones in soy. 
A food composition database may be used to provide a more consistent and accurate 
assessment of the intake of such nutrients. Assessing dietary intake alone may not 
accurately measure an individual’s exposure to specific constituents. Future studies should 
also endeavour to have reliable estimates of long-term exposure, and to be large enough to 
detect moderate effects. 
 
Investigations on dose-response would be helpful in substantiating potential associations. 
However, this is only made possible if studies were to measure intake and servings in 
quantifiable units that would facilitate pooled analysis. This also allows inferences to be 
drawn for dietary recommendations.  
 
Subgroup analysis of dietary isoflavone revealed a strong risk reduction for GI cancer, 
however the number of observational studies have been limited. Future studies should aim, 
wherever possible, to be prospective in nature and of significant size such that they have 
the necessary power to generate significant results.  
 
Given the inter-correlations between dietary practices and other confounders, studies 
should provide detailed information on adjustment of such variables to identify any true 
protective or harmful effects. An examination of the influences of variables such as 
preparation method, genetic polymorphisms, gender and ethnic differences would be 
particularly helpful.  
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Differences in results for anatomical subsite for GI cancer analyses provide suggestions on 
the potential biological mechanisms involved with specific nutrient intake. Future research 
may be productive if it can focus on biological pathways known to be relevant in the 
development of specific types of cancer.  
 
In conclusion, this study provides evidence that that cruciferous vegetable intake protects 
against cancer of the colon, with the consumption of broccoli in particular to be more 
beneficial. Egg consumption is associated with a positive dose-response association with the 
development of GI neoplasms in general. Soy intake as a food group is only associated with 
a small reduction in GI cancer risk while dietary isoflavone demonstrates a stronger inverse 
association. 
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